image_name stringlengths 68 68 | type stringclasses 2
values | gt_table stringlengths 116 12.6k | table_fragment_1 stringlengths 43 8.42k | table_fragment_2 stringlengths 39 8.21k |
|---|---|---|---|---|
5bb86068fa044128a025db6922fd083ec33a4017495b156bebce383993d9667b.png | simple | <table><tr><td>Particle</td><td>Loading capacity (%)</td><td>Loading efficiency (%)</td><td>Size (nm)</td><td>Administration route</td><td>In vitro/in vivo results</td><td>Ref.</td></tr><tr><td>NLCs (glyceryl tridecanoate, glyceryl tripalmitate, soy lecithin and Kolliphor HS15, and chitosan)</td><td>3</td><td>99</td><t... | <table><tr><td>Particle</td><td>Loading capacity (%)</td><td>Loading efficiency (%)</td><td>Size (nm)</td><td>Administration route</td><td>In vitro/in vivo results</td><td>Ref.</td></tr><tr><td>NLCs (glyceryl tridecanoate, glyceryl tripalmitate, soy lecithin and Kolliphor HS15, and chitosan)</td><td>3</td><td>99</td><t... | <table><tr><td>Particle</td><td>Loading efficiency (%)</td><td>Size (nm)</td><td>Administration route</td><td>In vitro/in vivo results</td><td>Ref.</td></tr><tr><td>arriers (Softisan® 100, Poloxamer 188, glycerol, Lipoid® S75, and CTAB/DDAB)</td><td>N/A</td><td>150</td><td>ular</td><td>medium. Permeation of rabbit corn... |
dab64efa2d5d74cb05a674909181ed876baa8baf86738648459fcf8af7efe7c1.png | complex | <table><tr><td rowspan="2">Variable</td><td colspan="2">Adherence</td><td rowspan="2">OR (95% CI)</td><td rowspan="2">p-value</td></tr><tr><td>Yes [n,(%)]</td><td>No [n,(%)]</td></tr><tr><td>Perceived benefits of DM drugs</td><td></td><td></td><td></td><td></td></tr><tr><td>A lot of benefits</td><td>251 (85.9)</td><td>... | <table><tr><td rowspan="2">Variable</td><td colspan="2">Adherence</td><td rowspan="2">OR (95% CI)</td><td rowspan="2">p-value</td></tr><tr><td>Yes [n,(%)]</td><td>No [n,(%)]</td></tr><tr><td>Perceived benefits of DM drugs</td><td></td><td></td><td></td><td></td></tr><tr><td>A lot of benefits</td><td>251 (85.9)</td><td>... | <table><tr><td rowspan="2">Variable</td><td colspan="2">Adherence</td><td rowspan="2">OR (95% CI)</td><td rowspan="2">p-value</td></tr><tr><td>Yes [n,(%)]</td><td>No [n,(%)]</td></tr><tr><td>More than one month</td><td>214 (84.6)</td><td>39 (15.6)</td><td>1.17 (0.73 – 1.87)</td><td>0.430</td></tr><tr><td>Use of alterna... |
ea056cba5bab12c0d233b476723405c72f6e88a34c2a3c1276565e88edd6efa1.png | complex | <table><tr><td>Model</td><td>Unstandardized Coefficients <i>B</i></td><td>Unstandardized Coefficients <i>SE</i></td><td>Standardized Coefficient <i>ß</i></td><td><i>t</i></td><td><i>p</i></td></tr><tr><td colspan="6">A. Results of the linear Regression for Variables Predicting PTSD Symptoms</td></tr><tr><td> Const... | <table><tr><td>Model</td><td>Unstandardized Coefficients B</td><td>Unstandardized Coefficients SE</td><td>Standardized Coefficient ß</td><td>t</td><td>p</td></tr><tr><td colspan="6">A. Results of the linear Regression for Variables Predicting PTSD Symptoms</td></tr><tr><td>Constant</td><td>−3.28</td><td>1.75</td><td></... | <table><tr><td>Model</td><td>Unstandardized Coefficients B</td><td>Unstandardized Coefficients SE</td><td>Standardized Coefficient ß</td><td>t</td><td>p</td></tr><tr><td>MACE SUM</td><td>0.21</td><td>0.06</td><td>.29</td><td>3.42</td><td>p = .001</td></tr><tr><td>Physical Neglect at age 5</td><td>2.28</td><td>0.80</td>... |
6e56fcac80ae20bcf9c50d9ddb55da4a8994ee66a3acfe651d88a269f046b155.png | simple | <table><tr><td>Phenotype</td><td>SNP</td><td>Chromosome</td><td>Position (bp)a</td><td>Alleleb</td><td>MAFc (%) in cases</td><td>MAFc (%) in controls</td><td>RRd (95% CI)</td><td><i>P</i> value</td><td>Nearby genee</td></tr><tr><td>BE</td><td>rs3072</td><td>2p24</td><td>20,741,887</td><td>G/A</td><td>38.1</td><td>37.0<... | <table><tr><td>Phenotype</td><td>SNP</td><td>Chromosome</td><td>Position (bp)a</td><td>Alleleb</td><td>MAFc (%) in cases</td><td>MAFc (%) in controls</td><td>RRd (95% CI)</td><td>P value</td><td>Nearby genee</td></tr><tr><td>BE</td><td>rs3072</td><td>2p24</td><td>20,741,887</td><td>G/A</td><td>38.1</td><td>37.0</td><td... | <table><tr><td>BE/EAC</td><td>rs3072</td><td>2p24</td><td>20,741,887</td><td>G/A</td><td>40.3</td><td>37.0</td><td>1.15 (1.04–1.27)</td><td>7.53 × 10−03</td><td>GDF7</td></tr><tr><td>BE/EAC</td><td>rs2701108</td><td>12q24</td><td>113,158,644</td><td>G/A</td><td>35.6</td><td>38.6</td><td>0.88 (0.79–0.97)</td><td>1.12 × ... |
18794042706e5487ef6e391bc5233ded5701e247ed2d8b0fd02f940d9b91d140.png | simple | <table><tr><td>Characteristic</td><td>Rotavirus Diarrhea (n = 71)</td><td>Nonrotavirus Diarrhea (n = 149)</td><td><i>P</i> Value</td></tr><tr><td>Age, mo<sup>a</sup></td><td>9 (3–27)</td><td>10 (2–30)</td><td>.335</td></tr><tr><td>Male sex</td><td>42 (59.2)</td><td>78 (52.3)</td><td>.422</td></tr><tr><td>Pr... | <table><tr><td>Characteristic</td><td>Rotavirus Diarrhea (n = 71)</td><td>Nonrotavirus Diarrhea (n = 149)</td><td>P Value</td></tr></table> | <table><tr><td>Age, moa</td><td>9 (3–27)</td><td>10 (2–30)</td><td>.335</td></tr><tr><td>Male sex</td><td>42 (59.2)</td><td>78 (52.3)</td><td>.422</td></tr><tr><td>Prior hospital admission for diarrhea</td><td>22 (31.0)</td><td>37 (24.8)</td><td>.423</td></tr><tr><td>Home has a separate room for kitchen</td><td>40 (56.... |
082dc3b7cfed1863d88b55421f223a10f0a02a82ba59b419eb12f4f6329edcce.png | simple | <table><tr><td>Author</td><td>Age</td><td>Symptoms</td><td>Site of tumor</td><td>Histology</td><td>Treatment</td><td>Relapse(months)</td><td>Treatment of relapse</td></tr><tr><td>Our case</td><td>56</td><td>Urinary symptomsLower abdominal distention</td><td>Corpus</td><td>IT</td><td>Hysterectomy</td><td>Yes (3)</td><td... | <table><tr><td>Author</td><td>Age</td><td>Symptoms</td><td>Site of tumor</td><td>Histology</td><td>Treatment</td><td>Relapse(months)</td><td>Treatment of relapse</td></tr><tr><td>Our case</td><td>56</td><td>Urinary symptomsLower abdominal distention</td><td>Corpus</td><td>IT</td><td>Hysterectomy</td><td>Yes (3)</td><td... | <table><tr><td>Author</td><td>Age</td><td>Symptoms</td><td>Site of tumor</td><td>Histology</td><td>Treatment</td><td>Relapse(months)</td><td>Treatment of relapse</td></tr><tr><td>009 [5]</td><td>82</td><td>bleeding</td><td></td><td>IT</td><td>pingooophorectomy</td><td>s (6)</td><td>T × 1, TP × 1 + surgery</td></tr><tr>... |
ee83663a219587c26faae1496362e8f086f771b6b4033e69ccf512333432e378.png | simple | <table><tr><td>n</td><td></td><td>1108</td></tr><tr><td>Age (yrs)</td><td>Median</td><td>61.5</td></tr><tr><td></td><td>Range</td><td>40.2-79</td></tr><tr><td>PSA (ng/ml)</td><td>Median</td><td>6.99</td></tr><tr><td></td><td>Range</td><td>0.3-20</td></tr><tr><td>Pathological Stage</td><td>pT2</td><td>770 (69.6%)</td></... | <table><tr><td>n</td><td></td><td>1108</td></tr><tr><td>Age (yrs)</td><td>Median</td><td>61.5</td></tr><tr><td></td><td>Range</td><td>40.2-79</td></tr><tr><td>PSA (ng/ml)</td><td>Median</td><td>6.99</td></tr><tr><td></td><td>Range</td><td>0.3-20</td></tr><tr><td>Pathological Stage</td><td>pT2</td><td>770 (69.6%)</td></... | <table><tr><td></td><td>1108</td></tr><tr><td>IQR</td><td>24.2-43.5</td></tr></table> |
ae9806d081d6c1a515e0ac9059c31c96cfd7b800fbcdcede0c57f136a8b97d23.png | complex | <table><tr><td></td><td>Expected</td><td colspan="2">Jinan</td><td colspan="2">Xuzhou</td><td colspan="2">Hefei</td><td colspan="2">Shanghai 2000</td><td colspan="2">Shanghai 1986</td></tr><tr><td>Centile</td><td>(%)</td><td>Boys</td><td>Girls</td><td>Boys</td><td>Girls</td><td>Boys</td><td>Girls</td><td>Boys</td><td>G... | <table><tr><td></td><td>Expected</td><td colspan="2">Jinan</td><td colspan="2">Xuzhou</td><td colspan="2">Hefei</td><td colspan="2">Shanghai 2000</td><td colspan="2">Shanghai 1986</td></tr><tr><td>Centile</td><td>(%)</td><td>Boys</td><td>Girls</td><td>Boys</td><td>Girls</td><td>Boys</td><td>Girls</td><td>Boys</td><td>G... | <table><tr><td></td><td>5</td><td>4.0</td><td>13.9</td><td></td><td>.2</td><td>4.1</td><td></td><td>7</td><td>.6</td><td>15.0</td><td>.3</td></tr><tr><td>95</td><td>5</td><td>5.7</td><td>4.9</td><td>5.3</td><td>5.0</td><td>5.4</td><td>4.3</td><td>5.5</td><td>4.8</td><td>3.8</td><td>5.2</td></tr><tr><td>97</td><td>2</td... |
8b1eedc61b7a77c4d8f8f84bb6aa091d745023b86a56a00e72eb594aa1bed506.png | complex | <table><tr><td></td><td colspan="2">Non smokersn = 19</td><td colspan="2">Ex-smokersn = 6</td><td colspan="2">Current smokersn = 14</td></tr><tr><td>Males (n, %)</td><td>7</td><td>36,8</td><td>6</td><td>100</td><td>11</td><td>78,6</td></tr><tr><td>Age, years; mean+SD</td><td>46,6</td><td>4</td><td>46</td><td>4,5</td><t... | <table><tr><td></td><td colspan="2">Non smokersn = 19</td><td colspan="2">Ex-smokersn = 6</td><td colspan="2">Current smokersn = 14</td></tr><tr><td>Males (n, %)</td><td>7</td><td>36,8</td><td>6</td><td>100</td><td>11</td><td>78,6</td></tr><tr><td>Age, years; mean+SD</td><td>46,6</td><td>4</td><td>46</td><td>4,5</td><t... | <table><tr><td>in IS</td><td>6</td><td>31,6</td><td colspan="2">0</td><td>2</td><td>14,3</td></tr></table> |
cfdde3ff3c0e533c8c349cc406146151c0dca69c12206d9f76db7b90ec03973b.png | complex | <table><tr><td rowspan="2">Parameter</td><td rowspan="2">Unit</td><td colspan="3">Tier within the breeding program</td></tr><tr><td>Nucleus</td><td>Multiplier</td><td>Commercial</td></tr><tr><td>Flock breeding ewes</td><td>Head</td><td>826</td><td>7000</td><td>180,000</td></tr><tr><td>Flock breeding rams</td><td>Head</... | <table><tr><td rowspan="2">Parameter</td><td rowspan="2">Unit</td><td colspan="3">Tier within the breeding program</td></tr><tr><td>Nucleus</td><td>Multiplier</td><td>Commercial</td></tr><tr><td>Flock breeding ewes</td><td>Head</td><td>826</td><td>7000</td><td>180,000</td></tr><tr><td>Flock breeding rams</td><td>Head</... | <table><tr><td rowspan="2">Parameter</td><td rowspan="2">Unit</td><td colspan="3">Tier within the breeding program</td></tr><tr><td>Nucleus</td><td>Multiplier</td><td>Commercial</td></tr><tr><td>ed age ewe lambing ratea</td><td>%</td><td>210</td><td>190</td><td>5</td></tr><tr><td>Ewe lamb lambing rate</td><td>%</td><td... |
0084e2d895ff11c95eb967f66bb3a0bf80b780cc08cdf18e263155361da5f048.png | complex | <table><tr><td></td><td></td><td colspan="3">Direct</td><td colspan="3">Indirect</td></tr><tr><td>IC1</td><td><i>n</i></td><td>2.5</td><td>50</td><td>97.5</td><td>2.5</td><td>50</td><td>97.5</td></tr><tr><td>Eire</td><td>1949</td><td>0.1</td><td>0.2</td><td>0.2</td><td>0.0</td><td>0.0</td><td>0.1</td></tr><tr><td>Great... | <table><tr><td></td><td></td><td colspan="3">Direct</td><td colspan="3">Indirect</td></tr><tr><td>IC1</td><td>n</td><td>2.5</td><td>50</td><td>97.5</td><td>2.5</td><td>50</td><td>97.5</td></tr><tr><td>Eire</td><td>1949</td><td>0.1</td><td>0.2</td><td>0.2</td><td>0.0</td><td>0.0</td><td>0.1</td></tr><tr><td>Great Britai... | <table><tr><td>Latin America</td><td>25</td><td>0.5</td><td>1.3</td><td>2.4</td><td>0.6</td><td>1.3</td><td>2.4</td></tr></table> |
cbd0561839dc5bae697016af8ebb908cdd7fba57a5f9d7dbb30edde3f6d068dd.png | simple | <table><tr><td></td><td></td><td></td><td></td><td>Cluster</td><td></td><td></td></tr><tr><td></td><td></td><td>Professional</td><td>Consumer</td><td>Organizational</td><td>Financial</td><td>Regulatory</td></tr><tr><td></td><td>Breast</td><td>4</td><td>9</td><td>4</td><td>0</td><td>0</td></tr><tr><td></td><td>Gastroint... | <table><tr><td></td><td></td><td></td><td></td><td>Cluster</td><td></td><td></td></tr><tr><td></td><td></td><td>Professional</td><td>Consumer</td><td>Organizational</td><td>Financial</td><td>Regulatory</td></tr><tr><td></td><td>Breast</td><td>4</td><td>9</td><td>4</td><td>0</td><td>0</td></tr><tr><td></td><td>Gastroint... | <table><tr><td></td><td></td><td></td><td>Cluster</td><td></td><td></td></tr><tr><td></td><td>Professional</td><td>Consumer</td><td>Organizational</td><td>Financial</td><td>Regulatory</td></tr><tr><td>Lung</td><td>0</td><td>3</td><td>0</td><td>0</td><td>0</td></tr><tr><td>Melanoma</td><td>1</td><td>1</td><td>1</td><td>... |
777437292bb9275519ee53d2572f7b08ce5e4145aeb5a8b6644cc3bb7157af46.png | simple | <table><tr><td></td><td>Laparoscopic cholecystectomy(n = 120)</td><td>Small-incision cholecystectomy(n = 137)</td><td>Statistical analysis</td></tr><tr><td>Mortality</td><td>0</td><td>0</td><td></td></tr><tr><td>Complications</td><td>21</td><td>16</td><td>p = 0.119</td></tr><tr><td>intra-operative</td><td>5</td><td>3</... | <table><tr><td></td><td>Laparoscopic cholecystectomy(n = 120)</td><td>Small-incision cholecystectomy(n = 137)</td><td>Statistical analysis</td></tr><tr><td>Mortality</td><td>0</td><td>0</td><td></td></tr><tr><td>Complications</td><td>21</td><td>16</td><td>p = 0.119</td></tr><tr><td>intra-operative</td><td>5</td><td>3</... | <table><tr><td></td><td>Laparoscopic cholecystectomy(n = 120)</td><td>Small-incision cholecystectomy(n = 137)</td><td>Statistical analysis</td></tr><tr><td>Failed symptom relief</td><td>11 (9.2%)</td><td>14 (10.2%)</td><td>p = 0.777</td></tr><tr><td>Operative time (min):</td><td></td><td></td><td></td></tr><tr><td>mean... |
45eeafe47335ce78a008486fb520ef90ef47e1ac3cf7fab6ddfa78d2f7d3206d.png | complex | <table><tr><td rowspan="2">Category from the VIM tool</td><td>Phase 1</td><td>Phase 3</td></tr><tr><td>112 patients</td><td>16 patients</td></tr><tr><td>Management—investigations, e.g. fields test</td><td>88% (99)</td><td>100% (16)</td></tr><tr><td>Self-management—importance of taking eyedrops</td><td>83% (... | <table><tr><td rowspan="2">Category from the VIM tool</td><td>Phase 1</td><td>Phase 3</td></tr><tr><td>112 patients</td><td>16 patients</td></tr><tr><td>Management—investigations, e.g. fields test</td><td>88% (99)</td><td>100% (16)</td></tr><tr><td>Self-management—importance of taking eyedrops</td><td>83% (93)</td><td>... | <table><tr><td rowspan="2">Category from the VIM tool</td><td>Phase 1</td><td>Phase 3</td></tr><tr><td>112 patients</td><td>16 patients</td></tr><tr><td>Support—support groups</td><td>10% (11)</td><td>94% (15)</td></tr><tr><td>Prognosis—when treated most don’t go blind</td><td>3% (3)</td><td>100% (16)</td></tr><tr><td>... |
45210f9cfd362e4b38cd7911204ffbea489666395199ce40f009e12204ef112e.png | complex | <table><tr><td rowspan="2">Variables</td><td rowspan="2">Coefficient</td><td rowspan="2">Standard error</td><td rowspan="2">p-value</td></tr><tr><td>Course year</td><td>- 0.542</td><td>0.215</td><td>0.015</td></tr><tr><td>Participation in emergency course</td><td>- 0.903</td><td>0.437</td><td>0.044</td></tr></table> | <table><tr><td rowspan="2">Varia</td><td rowspan="2">Coe</td><td rowspan="2">Stan</td><td rowspan="2">p-</td></tr><tr></tr></table> | <table><tr><td>bles</td><td>fficient</td><td>dard error</td><td>value</td></tr><tr><td>Course year</td><td>- 0.542</td><td>0.215</td><td>0.015</td></tr><tr><td>Participation in emergency course</td><td>- 0.903</td><td>0.437</td><td>0.044</td></tr></table> |
28d7744a454c39dc00233f16251be8fdda00cc97b8890a0ee5f527e229606f21.png | simple | <table><tr><td>Complication</td><td>Frequencyn</td><td>Percent%</td></tr><tr><td>Present</td><td>73</td><td>44.8</td></tr><tr><td>Absent</td><td>90</td><td>55.2</td></tr><tr><td>Total</td><td>163</td><td>100.0</td></tr></table> | <table><tr><td>Complication</td><td>Frequencyn</td><td>Percent%</td></tr><tr><td>Present</td><td>73</td><td>44.8</td></tr><tr><td>Absent</td><td>90</td><td>55.2</td></tr><tr><td>Tota</td><td></td><td>100.</td></tr></table> | <table><tr><td>Complication</td><td>Frequencyn</td><td>Percent%</td></tr><tr><td>l</td><td>163</td><td>0</td></tr></table> |
fed6486013eaafafa528f89fd76d9261c8c4a0292e9b4aec5e70fb81a2cf456d.png | complex | <table><tr><td>Warm-up 1.47 min</td><td>Front leaning stance</td><td>L stance</td></tr><tr><td>Begin with Postural alignment.Shoulders relaxed and in alignment with hips and feet and all facing forward. When standing, feet start shoulder width apart. Repeat each 4 times.</td><td>Step forward one stride length, toes fir... | <table><tr><td>Warm-up 1.47 min</td><td>Front leaning stance</td><td>L stance</td></tr><tr><td>Begin with Postural alignment.Shoulders relaxed and in alignment with hips and feet and all facing forward. When standing, feet start shoulder width apart. Repeat each 4 times.</td><td>Step forward one stride length, toes fir... | <table><tr><td>Warm-up 1.47 min</td><td>Front leaning stance</td><td>L stance</td></tr><tr><td colspan="3">Check blood pressure and heart rate at 0, 5, and 10 min. (Record heart rate every minute, and up to 10 min following cessation of movement.)</td></tr></table> |
d330e5a5950386ed39245b5d85184add58b32ed0d100368724684835f7395741.png | simple | <table><tr><td>miRNA gene</td><td>upstream TATA-box</td><td>ISRE-IRF1 M00972</td><td>IRF1 M00747</td><td>PU.1</td><td>GAS</td><td>IRF3 M00772</td><td>IRF8 M01665</td><td>NF-kappaB M00051</td><td>ETS2 M00340</td><td>Genbank Accesion #</td></tr><tr><td>miR462a/731 cluster</td><td>1</td><td>2</td><td>1</td><td>1</td><td>2... | <table><tr><td>miRNA gene</td><td>upstream TATA-box</td><td>ISRE-IRF1 M00972</td><td>IRF1 M00747</td><td>PU.1</td><td>GAS</td><td>IRF3 M00772</td><td>IRF8 M01665</td><td>NF-kappaB M00051</td><td>ETS2 M00340</td><td>Genbank Accesion #</td></tr><tr><td>miR462a/731 cluster</td><td>1</td><td>2</td><td>1</td><td>1</td><td>2... | <table><tr><td>ssa-mir-7132b-2</td><td>3</td><td>-</td><td>-</td><td>1</td><td>1</td><td>-</td><td>-</td><td>-</td><td>-</td><td>gi|925216720:24179665-24180926 (NC_027311.1)</td></tr><tr><td>ssa-mir-7132a-1</td><td>-</td><td>-</td><td>1</td><td>1</td><td>1</td><td>-</td><td>1</td><td>-</td><td>-</td><td>gi|925216772:70... |
09f509466b1e6127403f5b06167b3bab949060bbbc756a01fe509c14e25c57c0.png | simple | <table><tr><td>Groups</td><td>Treatment groups</td><td>Description</td></tr><tr><td>Group I</td><td>Normal control</td><td>Received only diet and water</td></tr><tr><td>Group II</td><td>Vehicle control</td><td>Received water and treated with SRBC</td></tr><tr><td>Group III</td><td>Positive control</td><td>Received Gins... | <table><tr><td>Groups</td><td>Treatment groups</td><td>Description</td></tr><tr><td>Group I</td><td>Normal control</td><td>Received only diet and water</td></tr><tr><td>Group II</td><td>Vehicle control</td><td>Received water and treated with SRBC</td></tr><tr><td>Group III</td><td>Positive control</td><td>Received Gins... | <table><tr><td>Groups</td><td>Treatment groups</td><td>Description</td></tr><tr><td>Group VI</td><td>High dosage treatment</td><td>Received 500 mg/kg of D. morbifera</td></tr></table> |
78c125a8d7a4ef10af1265b7761fa0f5c604a47706de55ead5ffcd04f4af8fc7.png | complex | <table><tr><td rowspan="2" colspan="2">Branch</td><td rowspan="2">Leading to<sup>a</sup></td><td rowspan="2">#Sets</td><td rowspan="2">#Genes in Sets</td><td colspan="3"># Significant Sets</td></tr><tr><td>Before Pruning</td><td>Without Top Scoring Gene</td><td>After Pruning</td></tr><tr><td>1</td><td>Homininae</td><td... | <table><tr><td rowspan="2" colspan="2">Branch</td><td rowspan="2">Leading toa</td><td rowspan="2">#Sets</td><td rowspan="2">#Genes in Sets</td><td colspan="3"># Significant Sets</td></tr><tr><td>Before Pruning</td><td>Without Top Scoring Gene</td><td>After Pruning</td></tr><tr><td></td><td>Hominin</td><td>Afr</td><td>1... | <table><tr><td>1</td><td>ae</td><td>ican Apes(Hu, Ch, Go)</td><td></td><td>0</td><td>8</td><td></td><td></td></tr><tr><td>2</td><td>Hominidae</td><td>Great Apes(Hu, Ch, Go, Or)</td><td>1,424</td><td>7,849</td><td>34</td><td>32</td><td>7</td></tr><tr><td>3</td><td>Hominoidae</td><td>Apes(Hu, Ch, Go, Gi)</td><td>1,441</t... |
2bbad3b4ab5a6c14ed1f6336667e4ebc383391f3ff46a71c2bd41742a2375961.png | simple | <table><tr><td>Gene ID</td><td>Annotation</td><td>FPKM Ctrl</td><td>FPKM -N</td><td>Log<sub>2</sub> FC</td></tr><tr><td>GRMZM2G326707</td><td>Inorganic phosphate transmembrane transporter, PHT1;4</td><td>73.0</td><td>305.5</td><td>2.07</td></tr><tr><td>GRMZM2G154090</td><td>Inorganic phosphate transmembrane transporter... | <table><tr><td>Gene ID</td><td>Annotation</td><td>FPKM Ctrl</td><td>FPKM -N</td><td>Log2 FC</td></tr><tr><td>GRMZM2G326707</td><td>Inorganic phosphate transmembrane transporter, PHT1;4</td><td>73.0</td><td>305.5</td><td>2.07</td></tr><tr><td>GRMZM2G154090</td><td>Inorganic phosphate transmembrane transporter, PHT1;4</t... | <table><tr><td>GRMZM2G008507</td><td>Sucrose-phosphate synthase</td><td>1.2</td><td>77.9</td><td>6.02</td></tr><tr><td>GRMZM2G047995</td><td>Lipase class 3 family protein</td><td>4.0</td><td>87.0</td><td>4.45</td></tr><tr><td>GRMZM2G169562</td><td>Lipase class 3 family protein</td><td>2.9</td><td>27.3</td><td>3.23</td>... |
63a4e5ecace13671e1ca8d29fc1dfa37a0cda107daf355ef6e9b7639377a89aa.png | simple | <table><tr><td></td><td>Metformin</td><td>Pioglitazone</td><td>Empagliflozin</td><td>Anticipated effect?</td></tr><tr><td>Cardiovascular death</td><td>↓</td><td>↔</td><td>↓↓</td><td>↓↓↓</td></tr><tr><td>All-cause death</td><td>↓</td><td>↔</td><td>↓↓</td>... | <table><tr><td></td><td>Metformin</td><td>Pioglitazone</td><td>Empagliflozin</td><td>Anticipated effect?</td></tr><tr><td>Cardiovascular death</td><td>↓</td><td>↔</td><td>↓↓</td><td>↓↓↓</td></tr><tr><td>All-cause death</td><td>↓</td><td>↔</td><td>↓↓</td><td>↓↓↓</td></tr><tr><td>Myocardial infarction</td><td>↓</td><td>↓... | <table><tr><td></td><td>Metformin</td><td>Pioglitazone</td><td>Empagliflozin</td><td>Anticipated effect?</td></tr><tr><td>Peripheral arterial disease</td><td>↓</td><td>↔</td><td>↔</td><td>↓</td></tr><tr><td>Fluid retention</td><td>↔</td><td>↑</td><td>↓</td><td>↔</td></tr><tr><td>Heart failure</td><td>↔</td><td>↑</td><t... |
7019fdcb324cfc9ee6ee6619a04a97e1257baac1c382aa5401b2c11e725eb966.png | complex | <table><tr><td colspan="2">Year</td><td>Confirmed positive</td><td>Donor population</td><td>Prevalence by gender</td><td>Total prevalence</td></tr><tr><td rowspan="2">1<sup>st</sup> year</td><td>Male</td><td>124</td><td>80253</td><td>0.15%</td><td rowspan="2">0.18%</td></tr><tr><td>Female</td><td>36</td><td>6524</td><t... | <table><tr><td colspan="2">Year</td><td>Confirmed positive</td><td>Donor population</td><td>Prevalence by gender</td><td>Total prevalence</td></tr><tr><td>1st year</td><td>Male</td><td>124</td><td>80253</td><td>0.15%</td><td>0.18%</td></tr></table> | <table><tr><td colspan="2">Year</td><td>Confirmed positive</td><td>Donor population</td><td>Prevalence by gender</td><td>Total prevalence</td></tr><tr><td>1st year</td><td>Female</td><td>36</td><td>6524</td><td>0.55%</td><td>0.18%</td></tr><tr><td rowspan="2">2nd year</td><td>Male</td><td>133</td><td>81841</td><td>0.16... |
85ac0e7734658de4f015eb075f92159a63a7b82c7341ddd9bc73db462db82e89.png | complex | <table><tr><td>Variable</td><td>Subgroups</td><td>Number of respondents</td><td>Percentages</td></tr><tr><td rowspan="3">Age (years)</td><td><20</td><td>33</td><td>11.3</td></tr><tr><td>20–25</td><td>221</td><td>75.4</td></tr><tr><td>>25</td><td>39</td><td>13.3</td></tr><tr><td rowspan="3">Age of menarche</... | <table><tr><td>Variable</td><td>Subgroups</td><td>Number of respondents</td><td>Percentages</td></tr><tr><td rowspan="3">Age (years)</td><td><20</td><td>33</td><td>11.3</td></tr><tr><td>20–25</td><td>221</td><td>75.4</td></tr><tr><td>>25</td><td>39</td><td>13.3</td></tr><tr><td rowspan="3">Age of menarche</td><td><13</... | <table><tr><td rowspan="3">years)</td><td>5</td><td>14</td><td>4.8</td></tr><tr><td>5–10</td><td>214</td><td>73.0</td></tr><tr><td>> 10</td><td>65</td><td>22.2</td></tr><tr><td rowspan="2">Religious affiliationa</td><td>Christianity</td><td>208</td><td>71.0</td></tr><tr><td>Islam</td><td>79</td><td>27.0</td></tr><tr><t... |
73133aaca543672c319c724dec7381d34781a64a4dae6a19967337a1ce51ac16.png | simple | <table><tr><td></td><td>Dyad 1</td><td>Dyad 2</td><td>Dyad 3</td><td>Dyad 4</td><td>Dyad 5</td></tr><tr><td>Mother age</td><td>43</td><td>31</td><td>52</td><td>45</td><td>48</td></tr><tr><td>Youth age</td><td>13</td><td>13</td><td>13</td><td>13</td><td>13</td></tr><tr><td>Youth grade</td><td>8</td><td>8</td><td>8</td><... | <table><tr><td></td><td>Dyad 1</td><td>Dyad 2</td><td>Dyad 3</td><td>Dyad 4</td><td>Dyad 5</td></tr><tr><td>Mother age</td><td>43</td><td>31</td><td>52</td><td>45</td><td>48</td></tr><tr><td>Youth age</td><td>13</td><td>13</td><td>13</td><td>13</td><td>13</td></tr><tr><td>Youth grade</td><td>8</td><td>8</td><td>8</td><... | <table><tr><td>Youth gender</td><td>Girl</td><td>Girl</td><td>Girl</td><td>Boy</td><td>Boy</td></tr><tr><td>Mother income</td><td>$40–49K</td><td>$10–19K</td><td>$50–74K</td><td>$75–99K</td><td>$50–74K</td></tr><tr><td>Mother education level</td><td>Some college</td><td>Some college</td><td>College graduate</td><td>Col... |
137b506d6abe9c0e529c2708c018d0ae9c22746f9e2fce5ff5ba291d0013daaf.png | complex | <table><tr><td></td><td>Number of responses</td><td>%</td><td>Overall(<i>N</i> Trusts with at least one response/Total N Trusts in region<sup>b</sup>)</td><td>Diabetes(<i>N</i> Trusts with at least one response)</td><td>Cardiac(<i>N</i> Trusts at least one response)</td></tr><tr><td colspan="6">ENGLAND</td></tr><tr><td... | <table><tr><td></td><td>Number of responses</td><td>%</td><td>Overall(N Trusts with at least one response/Total N Trusts in regionb)</td><td>Diabetes(N Trusts with at least one response)</td><td>Cardiac(N Trusts at least one response)</td></tr><tr><td colspan="6">ENGLAND</td></tr><tr><td>London</td><td>27</td><td>15.2<... | <table><tr><td>North West</td><td>17</td><td>9.6</td><td>10/20</td><td>8</td><td>8</td></tr><tr><td>Total number in England</td><td>161</td><td>90.5</td><td>92/139</td><td>76</td><td>72</td></tr><tr><td>SCOTLAND</td><td>12</td><td>6.7</td><td>12 responses covering ≥7/14 health boards (2 responses only identified as “Sc... |
90290c61a79dd3bdf256e251bd695601946f3fcd54fff01ceae6da913a8087d9.png | simple | <table><tr><td>Primer name</td><td>Sequence</td></tr><tr><td>Notch-1</td><td> </td></tr><tr><td> Forward</td><td>CACTGTGGGCGGGTCC</td></tr><tr><td> Reverse</td><td>GTTGTATTGGTTCGGCACCAT</td></tr><tr><td>Hes1</td><td> </td></tr><tr><td> Forward</td><td>AGCCAACTGAAAACACCTGATT</td></tr><tr><td> Reverse</td><td>GGAGTTTATGA... | <table><tr><td>Primer name</td><td>Sequence</td></tr><tr><td>Notch-1</td><td></td></tr><tr><td>Forward</td><td>CACTGTGGGCGGGTCC</td></tr><tr><td>Reverse</td><td>GTTGTATTGGTTCGGCACCAT</td></tr><tr><td>Hes1</td><td></td></tr><tr><td>Forward</td><td>AGCCAACTGAAAACACCTGATT</td></tr><tr><td>Reverse</td><td>GGAGTTTATGATTAGCA... | <table><tr><td>Primer name</td><td>Sequence</td></tr><tr><td>GAPDH</td><td></td></tr><tr><td>Forward</td><td>GGCATCCTGGGCTACACT</td></tr><tr><td>Reverse</td><td>CCACCACCCTGTTGCTGT</td></tr></table> |
827edb6f2a1fc39bb7fe932d8a5a08489d7245e34b6526be96294ecc24cb8ad1.png | simple | <table><tr><td>Features used</td><td>Attribute type</td></tr><tr><td>Gene Neighborhood score, obtained from STRING</td><td>Real valued, ranges from 0-999</td></tr><tr><td>Gene Fusion score, obtained from STRING</td><td>Real valued, ranges from 0-999</td></tr><tr><td>Gene Co-occurrence score, obtained from STRING</td><t... | <table><tr><td>Features use</td><td>Attribute</td></tr></table> | <table><tr><td>d</td><td> type</td></tr><tr><td>Gene Neighborhood score, obtained from STRING</td><td>Real valued, ranges from 0-999</td></tr><tr><td>Gene Fusion score, obtained from STRING</td><td>Real valued, ranges from 0-999</td></tr><tr><td>Gene Co-occurrence score, obtained from STRING</td><td>Real valued, ranges... |
7d60ce5e1171b1dbd4fa4cc027c830b6eeaad23cf7954e6bd501b82f19043882.png | complex | <table><tr><td></td><td>Number of cases</td><td>Gender (%)</td><td>Age median (Range)</td><td>PDAC stage (%)</td></tr><tr><td colspan="5">Cohort 1 (Exploratory phase)</td></tr><tr><td>Healthy</td><td><i>n</i> = 16</td><td>M (62.5)F (37.5)</td><td>59 (54–65)</td><td rowspan="2">Stage IA (16)Stage IIA (24)Stage IIB... | <table><tr><td></td><td>Number of cases</td><td>Gender (%)</td><td>Age median (Range)</td></tr><tr><td colspan="4">Cohort 1 (Exploratory phase)</td></tr><tr><td>Healthy</td><td>n = 16</td><td>M (62.5)F (37.5)</td><td>59 (54–65)</td></tr><tr><td>PDAC</td><td>n = 25</td><td>M (40)F (60)</td><td>50 (47–82)</td></tr><tr><t... | <table><tr><td>PDAC stage (%)</td></tr><tr><td>Cohort 1 (Exploratory phase)</td></tr><tr><td rowspan="2">Stage IA (16)Stage IIA (24)Stage IIB (56)ND (4)</td></tr><tr></tr><tr><td>Cohort 2 (Confirmatory phase)</td></tr><tr><td rowspan="3">Stage IA (1.5)Stage IB (0.8)Stage IIA (16.8)Stage IIB (66.4)Stage III (0.8)Stage I... |
747134fcefe6dfa6a07ae085f2a637779f4d398a29a17a4f2c2f350c913ea3e1.png | simple | <table><tr><td>Excipient</td><td>Recovery (% ± SD)<sup>(a)</sup></td></tr><tr><td>Starch (50)<sup>(b)</sup></td><td>99.46 ± 0.46</td></tr><tr><td>Glucose (10)</td><td>99.58 ± 1.23</td></tr><tr><td>Lactose (10)</td><td>100.37 ± 0.87</td></tr><tr><td>Acacia (10)</td><td>98.84 ± 0.39</td></tr><tr>... | <table><tr><td>Excipient</td><td>Recovery (% ± SD)(a)</td></tr></table> | <table><tr><td>Starch (50)(b)</td><td>99.46 ± 0.46</td></tr><tr><td>Glucose (10)</td><td>99.58 ± 1.23</td></tr><tr><td>Lactose (10)</td><td>100.37 ± 0.87</td></tr><tr><td>Acacia (10)</td><td>98.84 ± 0.39</td></tr><tr><td>Talc (5)</td><td>101.53 ± 1.02</td></tr><tr><td>MS(c)(10)</td><td>97.97 ± 1.26</td></tr><tr><td>Ave... |
1ad7e3f6b7dbba9249d11eade85b5baaa913c1ab98e043b3399ec0dfb04b2dd2.png | simple | <table><tr><td>Haplotypes</td><td>n (%)</td><td>Number of mutated positions</td><td>95% CI</td></tr><tr><td>Single-type(n = 27)</td><td></td><td></td><td></td></tr><tr><td>YEYSNVD</td><td>17 (60.7)</td><td>1</td><td>42.62 - 78.8</td></tr><tr><td>NEFSNVD</td><td>3 (10.7)</td><td>1</td><td>0 - 22.16</td></tr><tr><td>YEFS... | <table><tr><td>Haplotypes</td><td>n (%)</td><td>Number of mutated positions</td><td>95% CI</td></tr></table> | <table><tr><td>Single-type(n = 27)</td><td></td><td></td><td></td></tr><tr><td>YEYSNVD</td><td>17 (60.7)</td><td>1</td><td>42.62 - 78.8</td></tr><tr><td>NEFSNVD</td><td>3 (10.7)</td><td>1</td><td>0 - 22.16</td></tr><tr><td>YEFSNVD</td><td>1 (3.6)</td><td>2</td><td>0 - 10.44</td></tr><tr><td>NEYSNVD</td><td>6 (21.4)</td... |
154243a5097233fc00a0a919eda52901249162f4453058fe903780c742fa17a6.png | complex | <table><tr><td>Characteristics</td><td>Cases (<i>n</i> = 394)</td><td>Controls (<i>n</i> = 794)</td><td><i>p</i> value<sup>a</sup></td></tr><tr><td colspan="4">Marital status (%)</td></tr><tr><td> United<sup>b</sup></td><td>304 (77.2%)</td><td>636 (80.1%)</td><td rowspan="2">0.24</td></tr><tr><td> Not united</td><td>90... | <table><tr><td>Characteristics</td><td>Cases (n = 394)</td><td>Controls (n = 794)</td><td>p valuea</td></tr><tr><td colspan="4">Marital status (%)</td></tr><tr><td>Unitedb</td><td>304 (77.2%)</td><td>636 (80.1%)</td><td rowspan="2">0.24</td></tr><tr><td>Not united</td><td>90 (22.8%)</td><td>158 (19.9%)</td></tr></table... | <table><tr><td>Characteristics</td><td>Cases (n = 394)</td><td>Controls (n = 794)</td><td>p valuea</td></tr><tr><td colspan="4">Educational level (%)</td></tr><tr><td>Elementary school or less</td><td>177 (44.9%)</td><td>358 (45.1%)</td><td rowspan="4">< 0.001</td></tr><tr><td>Junior high school</td><td>66 (16.7%)</td>... |
65f75780de9df9e7c9d934c0dd5943671fcee6bb7021712cfd6b8b4649abc650.png | simple | <table><tr><td>Type of vaginal infections</td><td>Asymptomatic women (<i>N</i> = 261)</td><td>Symptomatic women (<i>N</i> = 148)</td><td><i>P</i>-value</td><td>Pregnant women (<i>N</i> = 214)</td><td>Non-pregnant women (<i>N</i> = 195)</td><td><i>P</i>-value</td><td>Total</td></tr><tr><td>Candidiasis</td><td>24 (9.2)</... | <table><tr><td>Type of vaginal infections</td><td>Asymptomatic women (N = 261)</td><td>Symptomatic women (N = 148)</td><td>P-value</td><td>Pregnant women (N = 214)</td><td>Non-pregnant women (N = 195)</td><td>P-value</td><td>Total</td></tr><tr><td>Candidiasis</td><td>24 (9.2)</td><td>10 (6.8)</td><td>0.08</td><td>20 (9... | <table><tr><td>Trichomoniasis</td><td>6 (2.3)</td><td>2 (1.4)</td><td>1.00</td><td>3 (1.4)</td><td>5 (2.6)</td><td>0.49</td><td>8 (2)</td></tr><tr><td>Gonococcus</td><td>4 (1.6)</td><td>0.0 %</td><td>0.58</td><td>2 (1)</td><td>2 (0.93)</td><td>1.00</td><td>4 (1)</td></tr><tr><td>Group B Streptococcus</td><td>4(1.5)</td... |
5b2c723d0b32b148d04c18fcb4af2cfda2af9eafa6410d2a0ed5d91a63528c57.png | complex | <table><tr><td rowspan="2">Variables</td><td colspan="2">KPNA2 expression</td><td rowspan="2"><i>P</i></td></tr><tr><td>Low (<i>N</i> = 23)</td><td>High (<i>N</i> = 80)</td></tr><tr><td>Mean age, y ± SD</td><td>66.9 ± 9.0</td><td>68.5 ± 8.9</td><td>0.513</td></tr><tr><td>Sex, <i>n</i> (%)</td><td></td><t... | <table><tr><td rowspan="2">Variables</td><td colspan="2">KPNA2 expression</td><td rowspan="2">P</td></tr><tr><td>Low (N = 23)</td><td>High (N = 80)</td></tr><tr><td>Mean age, y ± SD</td><td>66.9 ± 9.0</td><td>68.5 ± 8.9</td><td>0.513</td></tr><tr><td>Sex, n (%)</td><td></td><td></td><td>0.414</td></tr><tr><td>Male</td>... | <table><tr><td>on, n (%)</td><td></td><td></td><td></td></tr><tr><td>Absent</td><td>18 (78)</td><td>48 (60)</td><td></td></tr><tr><td>Present</td><td>5 (22)</td><td>32 (40)</td><td></td></tr><tr><td>Perineural invasion, n (%)</td><td></td><td></td><td>0.938</td></tr><tr><td>Absent</td><td>11 (48)</td><td>39 (49)</td><t... |
0fadd8febe8ae384769f5306d626e3481f27b9966cc4754be0618a9476895738.png | simple | <table><tr><td>Run no.</td><td>Pretreatment conditions</td><td>H<sub>2</sub>O addition method</td><td>Solid residue (wt%)</td><td>Glucose yield (%)</td><td>Xylose yield (%)</td></tr><tr><td>1</td><td>105°C 6 h</td><td>Aliquot</td><td>34.9</td><td>20.7 ± 0.4</td><td>99.8 ± 2.6</td></tr><tr><td>2<sup>b</su... | <table><tr><td>Run no.</td><td>Pretreatment conditions</td><td>H2O addition method</td><td>Solid residue (wt%)</td><td>Glucose yield (%)</td><td>Xylose yield (%)</td></tr><tr><td>1</td><td>105°C 6 h</td><td>Aliquot</td><td>34.9</td><td>20.7 ± 0.4</td><td>99.8 ± 2.6</td></tr></table> | <table><tr><td>Run no.</td><td>Pretreatment conditions</td><td>H2O addition method</td><td>Solid residue (wt%)</td><td>Glucose yield (%)</td><td>Xylose yield (%)</td></tr><tr><td>2b</td><td>105°C 6 h</td><td>Aliquot</td><td>34.8</td><td>24.2 ± 0.3</td><td>98.6 ± 1.8</td></tr><tr><td>3c</td><td>105°C 6 h</td><td>Aliquot... |
11cd20efc60a947c217c9916e28dd05102c2ba05cf78b545e49b1bf117b347c6.png | simple | <table><tr><td>Variables</td><td>Evaluation instruments</td><td>Quality of instruments</td><td>Time application instruments</td></tr><tr><td>Demographic & obstetric data</td><td>Included in antenatal interview</td><td> </td><td>Antenatal</td></tr><tr><td>Antenatal risk of PPD</td><td>Interview (Riguetti-Veltema &am... | <table><tr><td>Variables</td><td>Evaluation instruments</td><td>Quality of instruments</td><td>Time application instruments</td></tr><tr><td>Demographic & obstetric data</td><td>Included in antenatal interview</td><td></td><td>Antenatal</td></tr><tr><td>Antenatal risk of PPD</td><td>Interview (Riguetti-Veltema & et. al... | <table><tr><td>Variables</td><td>Evaluation instruments</td><td>Quality of instruments</td><td>Time application instruments</td></tr><tr><td>Symptoms of depression</td><td>EPDS*Edinburgh Postnatal Depression Scale (Cox & et. al, [51])</td><td>Sensitivity = 86%, Specificity = 78%</td><td>Antenatal and postnatal</td></tr... |
468621e558d972c63381abd425e8a4977bbf52436d5fd09fe3e833594a50ff16.png | complex | <table><tr><td>Characteristic</td><td>Frequency</td><td>Percentage</td></tr><tr><td colspan="3">Sex</td></tr><tr><td> Male</td><td>372</td><td>62.0</td></tr><tr><td> Female</td><td>228</td><td>38.0</td></tr><tr><td colspan="3">Age category</td></tr><tr><td> 1 (15–35)</td><td>287</td><td>47.8</td></tr><tr><td> 2 (... | <table><tr><td>Characteristic</td><td>Frequency</td><td>Percentage</td></tr><tr><td colspan="3">Sex</td></tr><tr><td>Male</td><td>372</td><td>62.0</td></tr><tr><td>Female</td><td>228</td><td>38.0</td></tr><tr><td colspan="3">Age category</td></tr><tr><td>1 (15–35)</td><td>287</td><td>47.8</td></tr></table> | <table><tr><td>2 (36–55)</td><td>202</td><td>33.7</td></tr><tr><td>3 (≥56)</td><td>111</td><td>18.5</td></tr><tr><td colspan="3">HIV status</td></tr><tr><td>Positive</td><td>162</td><td>27.0</td></tr><tr><td>Negative</td><td>438</td><td>73.0</td></tr><tr><td colspan="3">Mycobacterial testing results</td></tr><tr><td>ZN... |
c6890dbbf2e7eafcf45f5b5e8d38a26c290547dfc8b54844d6679c36da1edeeb.png | simple | <table><tr><td>BSI scale</td><td>UK outpatient mean/SD</td><td>Pretreatment score</td><td>Posttreatment score</td></tr><tr><td>PAR</td><td>M = 1.54/SD = 1.08∗</td><td>2.20</td><td>1.50</td></tr><tr><td>ANX</td><td>M = 1.87/SD = 1.03∗</td><td>2.50</td><td>1.60</td></tr></table> | <table><tr><td>BSI scale</td><td>UK outpatient mean/SD</td><td>Pretreatment score</td><td>Posttreatment score</td></tr></table> | <table><tr><td>PAR</td><td>M = 1.54/SD = 1.08∗</td><td>2.20</td><td>1.50</td></tr><tr><td>ANX</td><td>M = 1.87/SD = 1.03∗</td><td>2.50</td><td>1.60</td></tr></table> |
25e38c0757dcf13e8694434842f075260c2bb844c5a7b5d6a762f4553f3895f4.png | simple | <table><tr><td>Title</td><td>No of species</td><td>Authors</td><td>Reference</td></tr><tr><td>Sporadic study in India</td><td>20</td><td>Gosh A K, Maiti P K</td><td>[44]</td></tr><tr><td>Bhil of Rajasthan</td><td>17</td><td>Sharma S K</td><td>[43]</td></tr><tr><td>Bhil, Gamit, Kokna etc. of Maharastra</td><td>15</td><t... | <table><tr><td>Title</td><td>No of species</td><td>Authors</td><td>Reference</td></tr><tr><td>Sporadic study in India</td><td>20</td><td>Gosh A K, Maiti P K</td><td>[44]</td></tr><tr><td>Bhil of Rajasthan</td><td>17</td><td>Sharma S K</td><td>[43]</td></tr><tr><td>Bhil, Gamit, Kokna etc. of Maharastra</td><td>15</td><t... | <table><tr><td>Chakhesang of Nagaland</td><td>23</td><td>Kakati and Doulo</td><td>[16]</td></tr><tr><td>Naga tribe of Nagaland</td><td>26</td><td>Jamir N S et al.</td><td>[14]</td></tr><tr><td>Dibrugarh (Assam)</td><td>4</td><td>Dilip Kalita</td><td>[15]</td></tr><tr><td>Ao tribe of Nagaland</td><td>25</td><td>Kakati L... |
dab0b532cce0b4cf833e80737ae229fd1e15a3f0e43a7007917a34326e33d95c.png | simple | <table><tr><td>Material</td><td>Total thermal conductivity (W/m-K)</td><td>LA (%)</td><td>TA (%)</td><td>ZA (%)</td><td>Optical (%)</td></tr><tr><td>Black phosphorene (zigzag)</td><td>110</td><td>32</td><td>22</td><td>31</td><td>15</td></tr><tr><td>Black phosphorene (armchair)</td><td>36</td><td>28</td><td>33</td><td>1... | <table><tr><td>Material</td><td>Total thermal conductivity (W/m-K)</td><td>LA (%)</td><td>TA (%)</td><td>ZA (%)</td><td>Optical (%)</td></tr><tr><td>Black phosphorene (zigzag)</td><td>110</td><td>32</td><td>22</td><td>31</td><td>15</td></tr></table> | <table><tr><td>Material</td><td>Total thermal conductivity (W/m-K)</td><td>LA (%)</td><td>TA (%)</td><td>ZA (%)</td><td>Optical (%)</td></tr><tr><td>Black phosphorene (armchair)</td><td>36</td><td>28</td><td>33</td><td>12</td><td>27</td></tr><tr><td>Blue phosphorene</td><td>78</td><td>26</td><td>27</td><td>44</td><td>3... |
fc495986fe02b56e3940a06ef3661b73a26f669633063a2099d380aabacf1bcb.png | simple | <table><tr><td>Parameters</td><td>NGT</td><td>Pre-diabetes</td><td>p value</td></tr><tr><td></td><td>(n = 24)</td><td>(n = 26)</td><td></td></tr><tr><td>Anthropometric measures</td><td></td><td></td><td></td></tr><tr><td>Age (years)</td><td>36 ± 2</td><td>39 ± 2</td><td>0.232</td></tr><tr><td>Weight (Kg)</td>... | <table><tr><td>Parameters</td><td>NGT</td><td>Pre-diabetes</td><td>p value</td></tr><tr><td></td><td>(n = 24)</td><td>(n = 26)</td><td></td></tr><tr><td>Anthropometric measures</td><td></td><td></td><td></td></tr><tr><td>Age (years)</td><td>36 ± 2</td><td>39 ± 2</td><td>0.232</td></tr><tr><td>Weight (Kg)</td><td>69 ± 2... | <table><tr><td>2Hr Post plasma glucose (mmol/l)</td><td>5.6 ± 0.2</td><td>8.1 ± 0.3**</td><td>0.0001</td></tr><tr><td>Glycated Hemoglobin [HbA1c] (%)</td><td>5.4 ± 0.1</td><td>5.8 ± 0.1*</td><td>0.0013</td></tr><tr><td>Fasting Insulin (pmol/l)</td><td>49.8 ± 5</td><td>95.1 ± 10**</td><td>0.0002</td></tr><tr><td>2Hr pos... |
f6524035e484ac4cbc9c77c0ae5d5517effecd86ae4fae167218bcd77dbe9143.png | simple | <table><tr><td>Strain</td><td>Fold-change (light:dark)</td></tr><tr><td>A0047</td><td>1.01 ± 0.38</td></tr><tr><td>A0255</td><td>1.01 ± 0.25</td></tr><tr><td>A0304</td><td>1.29 ± 0.089</td></tr><tr><td>A0318</td><td>1.39 ± 0.34</td></tr><tr><td>A0670</td><td>1.31 ± 0.20</td></tr><tr><td>A0740</... | <table><tr><td>Strain</td><td>Fold-change (light:dark)</td></tr><tr><td>A0047</td><td>1.01 ± 0.38</td></tr><tr><td>A0255</td><td>1.01 ± 0.25</td></tr><tr><td>A0304</td><td>1.29 ± 0.089</td></tr><tr><td>A0318</td><td>1.39 ± 0.34</td></tr><tr><td>A0670</td><td>1.31 ± 0.20</td></tr><tr><td>A0740</td><td>1.44 ± 0.54</td></... | <table><tr><td>Strain</td><td>Fold-change (light:dark)</td></tr><tr><td>A2210</td><td>−1.34 ± 0.44</td></tr><tr><td>A2520</td><td>2.02 ± 0.90</td></tr><tr><td>A2531</td><td>1.35 ± 0.031</td></tr><tr><td>A2579</td><td>1.14 ± 0.45</td></tr><tr><td>A2595</td><td>1.45 ± 0.42</td></tr><tr><td>A2596</td><td>−1.05 ± 0.10</td>... |
bac750b3db8f0b4ad36b8157f5f92cd672a336cb5ef932a68f237ba6521e7112.png | complex | <table><tr><td>Groups</td><td>Compared with groups</td><td>Mean difference (I-J)</td><td>Std. Error</td><td>Sig.</td><td>Lower bound</td><td>Upper bound</td></tr><tr><td rowspan="3">1</td><td>2</td><td>-.80000</td><td>2.49933</td><td>.999</td><td>−8.5278</td><td>6.9278</td></tr><tr><td>3</td><td>4.00000</td><td>2... | <table><tr><td>Groups</td><td>Compared with groups</td><td>Mean difference (I-J)</td><td>Std. Error</td><td>Sig.</td><td>Lower bound</td><td>Upper bound</td></tr><tr><td rowspan="3">1</td><td>2</td><td>-.80000</td><td>2.49933</td><td>.999</td><td>−8.5278</td><td>6.9278</td></tr><tr><td>3</td><td>4.00000</td><td>2.49933... | <table><tr><td>3</td><td>4</td><td>−4.00000</td><td>2.49933</td><td>.606</td><td>−11.7278</td><td>3.7278</td></tr><tr><td rowspan="3">4</td><td>1</td><td>−6.60000</td><td>2.49933</td><td>.126</td><td>−14.3278</td><td>1.1278</td></tr><tr><td>2</td><td>.80000</td><td>2.49933</td><td>.999</td><td>−6.9278</td><td>8.5278</t... |
760b7231eb5d26c2807f0c00709ba745b7d2201f5cdcd9b30d31277b1c5b1ff4.png | simple | <table><tr><td></td><td>Case 1</td><td>Case 2</td><td>Case 3</td></tr><tr><td>Age, years</td><td>59</td><td>41</td><td>46</td></tr><tr><td>Sex</td><td>Female</td><td>Female</td><td>Female</td></tr><tr><td>Initial stage</td><td>1A</td><td>ND</td><td>2A</td></tr><tr><td>Histology</td><td>IDC</td><td>IDC</td><td>ILC</td><... | <table><tr><td></td><td>Case 1</td><td>Case 2</td><td>Case 3</td></tr><tr><td>Age, years</td><td>59</td><td>41</td><td>46</td></tr><tr><td>Sex</td><td>Female</td><td>Female</td><td>Female</td></tr><tr><td>Initial stage</td><td>1A</td><td>ND</td><td>2A</td></tr><tr><td>Histology</td><td>IDC</td><td>IDC</td><td>ILC</td><... | <table><tr><td>TERT hotspot mutation</td><td>C250T</td><td>C228T</td><td>C228T</td></tr><tr><td>Relapse-free survival, months</td><td>83</td><td>226</td><td>270</td></tr><tr><td>Overall survival, months</td><td>100</td><td>446</td><td>300</td></tr><tr><td>Status</td><td>Alive</td><td>Alive</td><td>Alive</td></tr></tabl... |
da3a12b857c73be510b74d79686568c73c664872b8c0096442f57b66ebb9d9e4.png | complex | <table><tr><td> </td><td> </td><td colspan="2">Women</td><td colspan="2">Men</td></tr><tr><td>Months from diagnosis</td><td>Services</td><td>IRR</td><td>95% CI</td><td>IRR</td><td>95% CI</td></tr><tr><td rowspan="3">−12 to −10</td><td>GP</td><td>1.07</td><td>1.06-1.09</td><td>1.13</td><td>1.12-1.15</td></tr... | <table><tr><td></td><td></td><td colspan="2">Women</td><td colspan="2">Men</td></tr><tr><td>Months from diagnosis</td><td>Services</td><td>IRR</td><td>95% CI</td><td>IRR</td><td>95% CI</td></tr><tr><td rowspan="3">−12 to −10</td><td>GP</td><td>1.07</td><td>1.06-1.09</td><td>1.13</td><td>1.12-1.15</td></tr><tr><td>Diagn... | <table><tr><td>7</td><td></td><td>1.24</td><td>1-1.28</td><td>.38</td><td>35-1.42</td></tr><tr><td rowspan="3">−6 to −4</td><td>GP</td><td>1.20</td><td>1.19-1.21</td><td>1.34</td><td>1.33-1.36</td></tr><tr><td>Diagnostics</td><td>1.66</td><td>1.61-1.71</td><td>2.08</td><td>2.02-2.15</td></tr><tr><td>Hospital</td><td>1.... |
d79126e6388e30d6b10d7f162782a2aaeb625cfddf33b64bfafb87b1fb9c89aa.png | complex | <table><tr><td>(A)</td><td>Healthy controls (<i>n</i> = 19)</td><td>ARMS (<i>n</i> = 19)</td><td>First-episode schizophrenia (<i>n</i> = 19)</td><td>Chronic schizophrenia (<i>n</i> = 19)</td><td colspan="2">Group comparison</td></tr><tr><td>Male/female</td><td>9/10</td><td>9/10</td><td>9/10</td><td>9/10</td><td colspan... | <table><tr><td>(A)</td><td>Healthy controls (n = 19)</td><td>ARMS (n = 19)</td><td>First-episode schizophrenia (n = 19)</td><td>Chronic schizophrenia (n = 19)</td><td colspan="2">Group comparison</td></tr><tr><td>Male/female</td><td>9/10</td><td>9/10</td><td>9/10</td><td>9/10</td><td colspan="2">n.s.</td></tr><tr><td>A... | <table><tr><td>Pz</td><td>2.0 (2.2)</td><td>1.8 (1.4)</td><td>2.3 (1.8)</td><td>1.8 (1.3)</td><td>0.408</td><td>0.74</td></tr><tr><td colspan="7">P3a latency (ms)</td></tr><tr><td>F3</td><td>255.6 (23.5)</td><td>265.2 (25.0)</td><td>264.2 (28.3)</td><td>262.8 (23.0)</td><td>0.395</td><td>0.75</td></tr><tr><td>F4</td><t... |
0e14d61bcc123f9d17a3985b78035c78018dd194c7a57d3efce55b8c32c7029d.png | simple | <table><tr><td>Code</td><td>Value</td><td>% Age</td><td>Description</td></tr><tr><td>J</td><td>165</td><td>2.51</td><td>Translation, ribosomal structure and biogenesis</td></tr><tr><td>A</td><td>0</td><td>0.00</td><td>RNA processing and modification</td></tr><tr><td>K</td><td>131</td><td>1.99</td><td>Transcription</td>... | <table><tr><td>Code</td><td>Value</td><td>% Age</td><td>Description</td></tr></table> | <table><tr><td>J</td><td>165</td><td>2.51</td><td>Translation, ribosomal structure and biogenesis</td></tr><tr><td>A</td><td>0</td><td>0.00</td><td>RNA processing and modification</td></tr><tr><td>K</td><td>131</td><td>1.99</td><td>Transcription</td></tr><tr><td>L</td><td>620</td><td>9.44</td><td>Replication, recombina... |
4c65d06762e002cf6e841aa6827c123a5ec9cdcf46ed357617716a32e1aacc56.png | complex | <table><tr><td rowspan="2">Characteristic</td><td colspan="2">rs3736228</td><td rowspan="2"><i>p</i>-value</td><td colspan="2">rs41494349</td><td rowspan="2"><i>p</i>-value</td><td colspan="2">rs2306862</td><td rowspan="2"><i>p</i>-value</td></tr><tr><td>CC</td><td>CT</td><td>AA</td><td>AG+GG</td><td>CC</td><td>CT+TT</... | <table><tr><td rowspan="2">Characteristic</td><td colspan="2">rs3736228</td><td rowspan="2">p-value</td><td colspan="2">rs41494349</td><td rowspan="2">p-value</td><td colspan="2">rs2306862</td><td rowspan="2">p-value</td></tr><tr><td>CC</td><td>CT</td><td>AA</td><td>AG+GG</td><td>CC</td><td>CT+TT</td></tr><tr><td>Age (... | <table><tr><td>cm2)</td><td>00–1.564)</td><td>55)</td><td>84</td><td>)</td><td> (0.778–1.353)</td><td>388</td><td>)</td><td>0.778–1.555)</td><td rowspan="2">87</td></tr><tr><td>N</td><td>160</td><td>45</td><td></td><td>183</td><td>22</td><td></td><td>147</td><td>46</td></tr><tr><td>Femoral neck BMD (g/cm2)</td><td>0.78... |
bfd9ea15fe9cf4d5aaf6b7c450cdcb7554572ff863817dc1fa7e753017bae9fd.png | simple | <table><tr><td>Period</td><td>Before education</td><td>First period of education</td><td>Second period of education</td><td>Total</td><td>p-value</td></tr><tr><td>Patients</td><td>276,541</td><td>78,052</td><td>56,950</td><td>411,543</td><td> </td></tr><tr><td>Age (years)</td><td>67.6 ± 17.3</td><td>68.5 ± 17... | <table><tr><td>Period</td><td>Before education</td><td>First period of education</td><td>Second period of education</td><td>Total</td><td>p-value</td></tr><tr><td>Patients</td><td>276,541</td><td>78,052</td><td>56,950</td><td>411,543</td><td></td></tr><tr><td>Age (years)</td><td>67.6 ± 17.3</td><td>68.5 ± 17.3</td><td>... | <table><tr><td>LOS (days)</td><td>11.0 ± 14.2</td><td>11.2 ± 13.8</td><td>10.6 ± 12.0</td><td>11.0 ± 13.8</td><td>< 0.0001</td></tr><tr><td>Hospital deaths (%)</td><td>17,270 (6.2)</td><td>5,237 (6.7)</td><td>3,732 (6.6)</td><td>26,239 (6.4)</td><td>< 0.0001</td></tr></table> |
6df0753687285f1e1b813b5890ea06e53018b3dd0aa7953c8e610623bbcb5251.png | simple | <table><tr><td>AA</td><td>Codon</td><td>N</td><td>RSCU</td><td>AA</td><td>Codon</td><td>N</td><td>RSCU</td></tr><tr><td>Ala</td><td>GCU</td><td>10137</td><td>0.61</td><td>Ile</td><td>AUU</td><td>4320</td><td>0.60</td></tr><tr><td></td><td>GCC</td><td>24014</td><td>1.45</td><td></td><td>AUC</td><td>15296</td><td>2.15</t... | <table><tr><td>AA</td><td>Codon</td><td>N</td><td>RSCU</td><td>AA</td><td>Codon</td><td>N</td><td>RSCU</td></tr><tr><td>Ala</td><td>GCU</td><td>10137</td><td>0.61</td><td>Ile</td><td>AUU</td><td>4320</td><td>0.60</td></tr><tr><td></td><td>GCC</td><td>24014</td><td>1.45</td><td></td><td>AUC</td><td>15296</td><td>2.15</t... | <table><tr><td>Leu</td><td>UUA</td><td>607</td><td>0.06</td><td></td><td>UGC</td><td>10191</td><td>1.68</td></tr><tr><td></td><td>UUG</td><td>9058</td><td>0.95</td><td>Asp</td><td>GAU</td><td>8318</td><td>0.50</td></tr><tr><td></td><td>CUU</td><td>6427</td><td>0.67</td><td></td><td>GAC</td><td>24990</td><td>1.50</td></... |
027668a9a29ed5777922572a33337d195dfe9b2a835cf789ecb0558ca94f72a6.png | complex | <table><tr><td>Variable</td><td>EVAM (n = 85)</td><td>OVAM (n = 439)</td><td><i>P</i> value</td></tr><tr><td colspan="4">Demographics</td></tr><tr><td> Age (years, mean ± SD)</td><td>5.6 ± 3.0</td><td>5.3 ± 3.1</td><td>NS</td></tr><tr><td colspan="4">Sex [no. (%)]</td></tr><tr><td> Male</td><td>50 (58.8)... | <table><tr><td>Variable</td><td>EVAM (n = 85)</td><td>OVAM (n = 439)</td><td>P value</td></tr><tr><td colspan="4">Demographics</td></tr><tr><td>Age (years, mean ± SD)</td><td>5.6 ± 3.0</td><td>5.3 ± 3.1</td><td>NS</td></tr></table> | <table><tr><td>Variable</td><td>EVAM (n = 85)</td><td>OVAM (n = 439)</td><td>P value</td></tr><tr><td colspan="4">Sex [no. (%)]</td></tr><tr><td>Male</td><td>50 (58.8)</td><td>250 (56.9)</td><td>NS</td></tr><tr><td>Female</td><td>35 (41.2)</td><td>189 (43.1)</td><td></td></tr><tr><td colspan="4">Clinical symptoms [no. ... |
90586d05c8611cad3baaf69bba3fdc0d0f42a7529df584c25db109a833e23601.png | complex | <table><tr><td>outcome</td><td>PHFWs</td><td>CHWs</td><td>Total</td><td> P-value</td></tr><tr><td></td><td>Number (%)</td><td>Number (%)</td><td>Number (%)</td><td></td></tr><tr><td>Child recovered</td><td></td><td></td><td></td><td><0.001*</td></tr><tr><td>Yes </td><td>254 (71.7)</td><td>346 (85.2)</td><td>600 (78.... | <table><tr><td>outcome</td><td>PHFWs</td><td>CHWs</td><td>Total</td><td>P-value</td></tr><tr><td></td><td>Number (%)</td><td>Number (%)</td><td>Number (%)</td><td></td></tr><tr><td>Child recovered</td><td></td><td></td><td></td><td><0.001*</td></tr><tr><td>Yes</td><td>254 (71.7)</td><td>346 (85.2)</td><td>600 (78.9)</t... | <table><tr><td>No</td><td>369 (92.5)</td><td>397 (94.7)</td><td>766 (93.6)</td><td></td></tr><tr><td>Total</td><td>399</td><td>419</td><td>818</td><td></td></tr><tr><td colspan="2">Behavioural change following treatment</td><td></td><td></td><td></td></tr><tr><td>Sleeping under a net</td><td></td><td></td><td></td><td>... |
4211e18a919b810218a7a29263883d71fe38e811e8b85469f2e3a5cecbd0d2b8.png | complex | <table><tr><td></td><td colspan="2">Mailed questionnaire</td><td colspan="2">Telephone interview</td></tr><tr><td></td><td>%</td><td>N</td><td>%</td><td>N</td></tr><tr><td>Gender</td><td></td><td></td><td></td><td></td></tr><tr><td>Men</td><td>50.5</td><td>1319</td><td>49.0</td><td>681</td></tr><tr><td>Women</td><td>49... | <table><tr><td></td><td colspan="2">Mailed questionnaire</td><td>Telephone interview</td></tr><tr><td></td><td>%</td><td>N</td><td>%</td></tr><tr><td>Gender</td><td></td><td></td><td></td></tr><tr><td>Men</td><td>50.5</td><td>1319</td><td>49.0</td></tr><tr><td>Women</td><td>49.5</td><td>1292</td><td>51.0</td></tr><tr><... | <table><tr><td>Telephone interview</td></tr><tr><td>N</td></tr><tr><td></td></tr><tr><td>681</td></tr><tr><td>708</td></tr><tr><td></td></tr><tr><td>352</td></tr><tr><td>347</td></tr><tr><td>351</td></tr><tr><td>339</td></tr><tr><td>1389</td></tr></table> |
fdc5aa2497f4307ffcae96f72be36e6c34b6157f385783a3033315797082fbbe.png | complex | <table><tr><td></td><td colspan="3">Type of ringworm</td><td></td></tr><tr><td>Dermatophytes</td><td>Tinea capitisn (%)</td><td>Tinea pedisn (%)</td><td>Tinea corporisn (%)</td><td>Totaln (%)</td></tr><tr><td><i>E. floccosum</i></td><td>0 (0.0)</td><td>1 (9.1)</td><td>0 (0.0)</td><td>1 (2.4)</td></tr><tr><td><i>M. audo... | <table><tr><td></td><td colspan="3">Type of ringworm</td><td></td></tr><tr><td>Dermatophytes</td><td>Tinea capitisn (%)</td><td>Tinea pedisn (%)</td><td>Tinea corporisn (%)</td><td>Totaln (%)</td></tr><tr><td>E. floccosum</td><td>0 (0.0)</td><td>1 (9.1)</td><td>0 (0.0)</td><td>1 (2.4)</td></tr></table> | <table><tr><td>M. audouinii</td><td>2 (6.7)</td><td>0 (0.0)</td><td>0 (0.0)</td><td>2 (4.8)</td></tr><tr><td>M. canis</td><td>14 (46.7)</td><td>0 (0.0)</td><td>1 (100.0)</td><td>15 (35.7)</td></tr><tr><td>T. mentagrophytes</td><td>4 (13.3)</td><td>4 (36.4)</td><td>0 (0.0)</td><td>8 (19.0)</td></tr><tr><td>T. rubrum</td... |
c89647bdc36aba6dc5cf0879828bddbf0822c3bcec81fc07d0bd2566670c3761.png | complex | <table><tr><td>SSRs</td><td>Probes used in study</td><td colspan="2">References</td></tr><tr><td></td><td></td><td>Mitotic chromosomes</td><td>Polytene chromosomes</td></tr><tr><td>A</td><td>A<sub>20</sub></td><td></td><td>(21, 40)</td></tr><tr><td>C</td><td>C<sub>20</sub></td><td></td><td>(40)</td></tr><tr><td>AC; AG<... | <table><tr><td>SSRs</td><td>Probes used in study</td><td colspan="2">References</td></tr><tr><td></td><td></td><td>Mitotic chromosomes</td><td>Polytene chromosomes</td></tr><tr><td>A</td><td>A20</td><td></td><td>(21, 40)</td></tr><tr><td>C</td><td>C20</td><td></td><td>(40)</td></tr></table> | <table><tr><td>SSRs</td><td>Probes used in study</td><td colspan="2">References</td></tr><tr><td></td><td></td><td>Mitotic chromosomes</td><td>Polytene chromosomes</td></tr><tr><td>AC; AG</td><td>(AC)10; (AG)10</td><td>(27)</td><td>(27, 40)</td></tr><tr><td>AAC; AAG; AAT, AAC; AGC; ACT; AGC; AGG; ATC; CCG</td><td>(AAC)... |
ef61a19f279e852f9da201a122247a77037da9e43ff4c88aed4dc734f4bf69d2.png | complex | <table><tr><td></td><td></td><td><i>N</i> = 14 (%)</td></tr><tr><td>Clinical characteristics</td><td></td></tr><tr><td>Age (SAH), years (mean, SD)</td><td></td><td>46.1 ± 12Range: 20–63</td></tr><tr><td>Age (healthy controls), years (mean, SD)</td><td></td><td>47.1 ± 12Range: 20–64</td></tr><tr><t... | <table><tr><td></td><td></td><td>N = 14 (%)</td></tr><tr><td>Clinical characteristics</td><td></td><td></td></tr><tr><td>Age (SAH), years (mean, SD)</td><td></td><td>46.1 ± 12Range: 20–63</td></tr><tr><td>Age (healthy controls), years (mean, SD)</td><td></td><td>47.1 ± 12Range: 20–64</td></tr><tr><td>Gender (SAH), fema... | <table><tr><td></td><td></td><td>N = 14 (%)</td></tr><tr><td>mFisher scale</td><td>4</td><td>5 (36)</td></tr><tr><td>SAH sum score</td><td></td><td>13Range: 10–15</td></tr><tr><td>IVH sum score</td><td></td><td>0 (0–2)</td></tr><tr><td>Aneurysm location AcomA = anterior communicating artery</td><td></td><td>5 (36)</td>... |
308b3d295b35bd63ba560dcb727878889a9fb7b7702ff3304d8fca39f5e1821f.png | complex | <table><tr><td></td><td colspan="4">Model 1</td><td colspan="4">Model 2</td></tr><tr><td>Variable</td><td><i>B</i></td><td><i>SE</i></td><td>β</td><td><i>t</i></td><td><i>B</i></td><td><i>SE</i></td><td>β</td><td><i>t</i></td></tr><tr><td>Gender</td><td></td><td></td><td></td><td></td><td>–0.408</td><td... | <table><tr><td></td><td>Model 1</td></tr><tr><td>Variable</td><td>B</td></tr><tr><td>Gender</td><td></td></tr><tr><td>Age</td><td></td></tr><tr><td>Self-esteem</td><td>–0.611</td></tr><tr><td>Condition (1 = materialism, –1 = control)</td><td>0.498</td></tr><tr><td>Self-esteem × Condition</td><td>0.487</td></tr><tr><td>... | <table><tr><td colspan="3">Model 1</td><td colspan="4">Model 2</td></tr><tr><td>SE</td><td>β</td><td>t</td><td>B</td><td>SE</td><td>β</td><td>t</td></tr><tr><td></td><td></td><td></td><td>–0.408</td><td>0.419</td><td>–0.084</td><td>–0.974</td></tr><tr><td></td><td></td><td></td><td>0.090</td><td>0.075</td><td>0.106</td... |
dc16416b7035dc3176dab664a0b7e5ad15a6291cd3c111be94f7b368661968af.png | complex | <table><tr><td>Location</td><td>Tissue</td><td>Date of collection</td><td>Time period reflected</td><td><i>N</i></td><td><i>N</i> males</td><td><i>N</i> females</td></tr><tr><td rowspan="2">Newfoundland</td><td>Claws</td><td>April 2016</td><td>Winter</td><td>24</td><td>8</td><td>16</td></tr><tr><td>Whole blood</td><td>... | <table><tr><td>Location</td><td>Tissue</td><td>Date of collection</td><td>Time period reflected</td><td>N</td><td>N males</td><td>N females</td></tr><tr><td rowspan="2">Newfoundland</td><td>Claws</td><td>April 2016</td><td>Winter</td><td>24</td><td>8</td><td>16</td></tr><tr><td>Whole blood</td><td>December 2013 to Janu... | <table><tr><td rowspan="3">East Bay Island</td><td>Red blood cells</td><td>June to July 2014</td><td>Spring migration</td><td>108</td><td>0</td><td>108</td></tr><tr><td>Claws</td><td>June to July 2015</td><td>Winter</td><td>115</td><td>43</td><td>72</td></tr><tr><td>Red blood cells</td><td>June to July 2015</td><td>Spr... |
eb815b8a4d69aea5df6023e110a2666e06cb1ef17f76069cd23af20424e7319f.png | simple | <table><tr><td>Suggestions from COECSA partners</td><td>Suggestions from United Kingdom partners</td></tr><tr><td><i>Program planning and design</i>• There is need for continuous dialog and joint planning• COECSA to drive the process by demonstrating both demand and ownership• More opportunities for v... | <table><tr><td>Suggestions from COECSA partners</td><td>Suggestions from United Kingdom partners</td></tr></table> | <table><tr><td>Program planning and design• There is need for continuous dialog and joint planning• COECSA to drive the process by demonstrating both demand and ownership• More opportunities for visits to the United Kingdom to “see how things are done”• LINK to facilitate setting up of more VISION 2020 twinning links i... |
967e843d1347b58b68caa33667f602b04d1fb3461e130937d318e89a60b0a2fe.png | complex | <table><tr><td></td><td colspan="6">BMI (<i>kg</i>/<i>m</i><sup>2</sup>)</td></tr><tr><td></td><td>Overall</td><td>Underweight</td><td>Normal</td><td>Overweight</td><td>Obese I</td><td>Obese II/III</td></tr><tr><td>Males (n = 55,303)</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Diabetes melli... | <table><tr><td></td><td colspan="6">BMI (kg/m2)</td></tr></table> | <table><tr><td></td><td>Overall</td><td>Underweight</td><td>Normal</td><td>Overweight</td><td>Obese I</td><td>Obese II/III</td></tr><tr><td>Males (n = 55,303)</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Diabetes mellitus</td><td>4.27</td><td>1.74 (106)</td><td>2.93 (100)</td><td>4.85 (144)</t... |
f6cb25e6ebf6ef0c341fcdd8ed614c7e4e8f39037a835cd51109bb941615ac6c.png | complex | <table><tr><td></td><td>STAV-AB xenograft</td><td>STAV-FCS xenograft</td><td>Localization</td></tr><tr><td colspan="4">MESOTHELIAL AND EPITHELIAL MARKERS</td></tr><tr><td>Calretinin</td><td>++</td><td>++</td><td>Cytoplasm and nucleus</td></tr><tr><td>EMA</td><td>+</td><td>+(+)</td><td>Cell membrane</td></tr><tr><td>E-c... | <table><tr><td></td><td>STAV-AB xenograft</td><td>STAV-FCS xenograft</td></tr><tr><td colspan="3">MESOTHELIAL AND EPITHELIAL MARKERS</td></tr><tr><td>Calretinin</td><td>++</td><td>++</td></tr><tr><td>EMA</td><td>+</td><td>+(+)</td></tr><tr><td>E-cadherin</td><td>+ (Focal)</td><td>+</td></tr><tr><td>CK-HMW</td><td>++</t... | <table><tr><td>Localization</td></tr><tr><td>MESOTHELIAL AND EPITHELIAL MARKERS</td></tr><tr><td>Cytoplasm and nucleus</td></tr><tr><td>Cell membrane</td></tr><tr><td>Cell membrane</td></tr><tr><td>Cytoplasm</td></tr><tr><td>Cytoplasm</td></tr><tr><td>Cytoplasm</td></tr><tr><td>Cell membrane and cytoplasm</td></tr><tr>... |
decc994da4150d1be12cbfebf8ffcfff3e9034862defee23cef42df2b251ebec.png | complex | <table><tr><td></td><td></td><td>Poorest</td><td>Poorer</td><td>Middle</td><td>Richer</td><td>Richest</td><td>All</td></tr><tr><td rowspan="4">OOP</td><td>Non-chronic</td><td>2287.30</td><td>2550.10</td><td>2854.72</td><td>3057.06</td><td>4013.26</td><td>2952</td></tr><tr><td>Hypertension</td><td>2378.66</td><td>3352.3... | <table><tr><td></td><td></td><td>Poorest</td><td>Poorer</td><td>Middle</td><td>Richer</td><td>Richest</td><td>All</td></tr><tr><td rowspan="4">OOP</td><td>Non-chronic</td><td>2287.30</td><td>2550.10</td><td>2854.72</td><td>3057.06</td><td>4013.26</td><td>2952</td></tr><tr><td>Hypertension</td><td>2378.66</td><td>3352.3... | <table><tr><td rowspan="4">CTP</td><td>Non-chronic</td><td>5471.32</td><td>9215.98</td><td>13688.45</td><td>20350.67</td><td>38227.57</td><td>17380</td></tr><tr><td>Hypertension</td><td>4635.55</td><td>8450.70</td><td>11313.45</td><td>17624.12</td><td>37316.36</td><td>15835</td></tr><tr><td>Hypertension and else</td><t... |
fc45432ff6b9f8d2368a667af7d598ffe9656c4ab9ab05404dabfa2c886f4f28.png | simple | <table><tr><td>Antibody</td><td>Supplier</td><td>Western dilution</td></tr><tr><td>β-Actin</td><td>Sigma Aldrich</td><td>1 in 3000</td></tr><tr><td>CDK6</td><td>Santa Cruz</td><td>1 in 200</td></tr><tr><td>γH2AX (Ser139)</td><td>Cell Signaling</td><td>1 in 1000</td></tr><tr><td>Lamin a/c</td><td>Santa Cruz</t... | <table><tr><td>Antibody</td><td>Supplier</td><td>Western dilution</td></tr><tr><td>β-Actin</td><td>Sigma Aldrich</td><td>1 in 3000</td></tr><tr><td>CDK6</td><td>Santa Cruz</td><td>1 in 200</td></tr><tr><td>γH2AX (Ser139)</td><td>Cell Signaling</td><td>1 in 1000</td></tr><tr><td>Lamin a/c</td><td>Santa Cruz</td><td>1 in... | <table><tr><td>Antibody</td><td>Supplier</td><td>Western dilution</td></tr><tr><td>p63(TA)</td><td>bioLegend</td><td>1 in 1000</td></tr></table> |
aec113edb2c1a92e04c56f26cbb98d3e2850360885b2adf8642add4f921399c2.png | complex | <table><tr><td></td><td></td><td></td><td colspan="3">three to five days</td><td colspan="3">17-19 days</td></tr><tr><td>Net</td><td>Family No.</td><td>Species*</td><td>N</td><td>No. Dead</td><td>% Mortality</td><td>N</td><td>No. Dead</td><td>% Mortality</td></tr><tr><td>LLIN#1</td><td>1</td><td>S</td><td>10</td><td>0<... | <table><tr><td></td><td></td><td></td><td colspan="3">three to five days</td><td colspan="3">17-19 days</td></tr><tr><td>Net</td><td>Family No.</td><td>Species*</td><td>N</td><td>No. Dead</td><td>% Mortality</td><td>N</td><td>No. Dead</td><td>% Mortality</td></tr><tr><td>LLIN#1</td><td>1</td><td>S</td><td>10</td><td>0<... | <table><tr><td></td><td></td><td></td><td colspan="3">three to five days</td><td colspan="3">17-19 days</td></tr><tr><td></td><td>1203</td><td>S</td><td>9</td><td>0</td><td>0.0</td><td>10</td><td>1</td><td>10.0</td></tr></table> |
d8040b9de7c073f56f96cc3e754b677d80abda40c56ceaacc9fb6d4a63537de1.png | complex | <table><tr><td>Characteristic</td><td>Boys 8 years of age (<i>n</i> = 304)</td><td>Boys 9 years of age (<i>n</i> = 185)</td><td>Total boys (<i>n</i> = 489)</td></tr><tr><td colspan="4">Growth and sexual maturation parameters</td></tr><tr><td>Age [years (mean ± SD)]</td><td>8.04 ± 0.10</td><td>9.02 ± 0.08... | <table><tr><td>Characteristic</td><td>Boys 8 years of age (n = 304)</td><td>Boys 9 years of age (n = 185)</td><td>Total boys (n = 489)</td></tr><tr><td colspan="4">Growth and sexual maturation parameters</td></tr><tr><td>Age [years (mean ± SD)]</td><td>8.04 ± 0.10</td><td>9.02 ± 0.08</td><td>8.41 ± 0.49</td></tr><tr><t... | <table><tr><td>Characteristic</td><td>Boys 8 years of age (n = 304)</td><td>Boys 9 years of age (n = 185)</td><td>Total boys (n = 489)</td></tr><tr><td>1</td><td>8 (3)</td><td>4 (2)</td><td>12 (2)</td></tr><tr><td>2</td><td>151 (50)</td><td>80 (44)</td><td>231 (48)</td></tr><tr><td>3</td><td>108 (36)</td><td>66 (36)</t... |
35c072788bdd1723961143be8a76bd44a478496a39a4665d007b9f9c79e3a8be.png | simple | <table><tr><td>Tocopherol</td><td>Cell type/Cancer model</td><td>Result</td><td>References</td></tr><tr><td>α-Tocopherol</td><td>Human retinal pigment epithelial cells (ARPE-19)</td><td>↑ Nrf2 protein levels, ↑ glutamate cysteine ligase, NQO1, HO-1, GST, SOD</td><td>[90]</td></tr><tr><td>γ-TmT</td... | <table><tr><td>Tocopherol</td><td>Cell type/Cancer model</td><td>Result</td><td>References</td></tr><tr><td>α-Tocopherol</td><td>Human retinal pigment epithelial cells (ARPE-19)</td><td>↑ Nrf2 protein levels, ↑ glutamate cysteine ligase, NQO1, HO-1, GST, SOD</td><td>[90]</td></tr></table> | <table><tr><td>Tocopherol</td><td>Cell type/Cancer model</td><td>Result</td><td>References</td></tr><tr><td>γ-TmT</td><td>Prostate carcinogenesis in TRAMP male mice</td><td>↑ Nrf2 protein levels, ↑ GSTm1, UGT1A1, HO-1, catalase, SOD, glutathione peroxidase,</td><td>[43]</td></tr><tr><td>γ-TmT</td><td>Estrogen-induced m... |
dd4d005cab9a0dd24485262640d5ec8cc112c04a2124cfd545a43870119de4f4.png | simple | <table><tr><td>Sample</td><td>Mean ± SD</td></tr><tr><td>Blank</td><td>1.247 ± 0.004</td></tr><tr><td>VC, 0.01 mM (1.7 mg/mL)</td><td>0.045 ± 0.003 *</td></tr><tr><td>BCE, 2.5 μL (875 μg/μL)</td><td>0.668 ± 0.016 *</td></tr><tr><td>BCE, 5 μL (875 μg/μL)</td><td>0.368 &#... | <table><tr><td>Sample</td><td>Mean ± SD</td></tr><tr><td>Blank</td><td>1.247 ± 0.004</td></tr><tr><td>VC, 0.01 mM (1.7 mg/mL)</td><td>0.045 ± 0.003 *</td></tr><tr><td>BCE, 2.5 μL (875 μg/μL)</td><td>0.668 ± 0.016 *</td></tr><tr><td>BCE, 5 μL (875 μg/μL)</td><td>0.368 ± 0.018 *</td></tr><tr><td>BCE, 10 μL (875 μg/μL)</t... | <table><tr><td>BCE, 80 μL (875 μg/μL)</td><td>0.074 ± 0.003 *</td></tr></table> |
0b504c31c3f640e225ed5e65c5efb2ea56c81093c6e818261c97ae219e8219fa.png | simple | <table><tr><td> </td><td>CBHI (26)</td><td>Non-CBHI (114)</td><td>t-test</td></tr><tr><td>Population density (per km2)</td><td>184.62</td><td>46.42</td><td>-2.571*</td></tr><tr><td>Poverty rate (%)</td><td>29.6</td><td>40.1</td><td>3.386**</td></tr><tr><td>Literacy rate (%)</td><td>79.00</td><td>64.2</td><td>-4.061**</... | <table><tr><td></td><td>CBHI (26)</td><td>Non-CBHI (114)</td><td>t-test</td></tr><tr><td>Population density (per km2)</td><td>184.62</td><td>46.42</td><td>-2.571*</td></tr><tr><td>Poverty rate (%)</td><td>29.6</td><td>40.1</td><td>3.386**</td></tr><tr><td>Literacy rate (%)</td><td>79.00</td><td>64.2</td><td>-4.061**</t... | <table><tr><td>% HHs with electricity</td><td>73.7</td><td>41.87</td><td>-5.948**</td></tr><tr><td>Avg time to nearest health center (mins)</td><td>57.65</td><td>161</td><td>4.5322**</td></tr><tr><td>% pop Lao-tai (vs. ethnic minority)</td><td>56.09</td><td>26.93</td><td>-3.741**</td></tr><tr><td>% pop Buddhist</td><td... |
dd11dd085145bfd88f8fc31118787f11b6560c53f659f845139c9cdcd930a5b2.png | simple | <table><tr><td>Characteristic</td><td>Amiodarone n=20</td><td>Metaprolol n=30</td><td><i>P value</i></td></tr><tr><td>AF%age</td><td>20%</td><td>26.7%</td><td>NS</td></tr><tr><td>Time of Development of AF</td><td>62.15+ 18</td><td>48.4+ 10.2</td><td>NS</td></tr><tr><td>Duration of AF</td><td>12.04+ 10.2</td><td>18.8+ 1... | <table><tr><td>Characteristic</td><td>Amiodarone n=20</td><td>Metaprolol n=30</td><td>P value</td></tr><tr><td>AF%age</td><td>20%</td><td>26.7%</td><td>NS</td></tr><tr><td>Time of Development of AF</td><td>62.15+ 18</td><td>48.4+ 10.2</td><td>NS</td></tr><tr><td>Duration of AF</td><td>12.04+ 10.2</td><td>18.8+ 10.4</td... | <table><tr><td>Characteristic</td><td>Amiodarone n=20</td><td>Metaprolol n=30</td><td>P value</td></tr><tr><td>Length of hospital stay</td><td>12.7+ 4.5</td><td>13.2+ 5.2</td><td>NS</td></tr><tr><td>Cost of Care</td><td>1.17+ 0.12</td><td>1.18+0.10</td><td>NS</td></tr></table> |
f116547cda6c48cb9d34d52f1648acbc2dd2f610012e533710aaf0d1a5cde017.png | simple | <table><tr><td>Characteristics</td><td>Number of patients (%)</td></tr><tr><td>Sex</td><td></td></tr><tr><td>Male</td><td>42 (98)</td></tr><tr><td>Female</td><td>1 (2)</td></tr><tr><td>Age (years)</td><td></td></tr><tr><td>Range</td><td>39–80</td></tr><tr><td>Median</td><td>66</td></tr><tr><td>Stage</td><td></td>... | <table><tr><td>Characteristics</td><td>Number of patients (%)</td></tr><tr><td>Sex</td><td></td></tr><tr><td>Male</td><td>42 (98)</td></tr><tr><td>Female</td><td>1 (2)</td></tr><tr><td>Age (years)</td><td></td></tr><tr><td>Range</td><td>39–80</td></tr><tr><td>Median</td><td>66</td></tr><tr><td>Stage</td><td></td></tr><... | <table><tr><td>Characteristics</td><td>Number of patients (%)</td></tr><tr><td>Mucinous</td><td>10 (23.3)</td></tr><tr><td>Wood dust exposure</td><td></td></tr><tr><td>Yes</td><td>26 (60)</td></tr><tr><td>No</td><td>9 (21)</td></tr><tr><td>NA</td><td>8 (19)</td></tr><tr><td>Recurrence</td><td></td></tr><tr><td>Yes</td>... |
89c862a9ef395009d9740724d114bb99bcdfc259cb8a13cb3906f006c4e09fa6.png | complex | <table><tr><td colspan="3">Before the phlebotomy training May 2014</td><td colspan="3">After the phlebotomy training July 2014</td></tr><tr><td>CHC/CDC</td><td>Blood registrations</td><td>Blood rejections <i>n</i> (%)</td><td>Blood registrations</td><td>Blood rejections <i>n</i> (%)</td><td><i>p</i></td></tr><tr><td>A<... | <table><tr><td colspan="3">Before the phlebotomy training May 2014</td><td colspan="3">After the phlebotomy training July 2014</td></tr><tr><td>CHC/CDC</td><td>Blood registrations</td><td>Blood rejections n (%)</td><td>Blood registrations</td><td>Blood rejections n (%)</td><td>p</td></tr><tr><td>A</td><td>7557</td><td>... | <table><tr><td colspan="3">Before the phlebotomy training May 2014</td><td colspan="3">After the phlebotomy training July 2014</td></tr><tr><td>CHC/CDC</td><td>Blood registrations</td><td>Blood rejections n (%)</td><td>Blood registrations</td><td>Blood rejections n (%)</td><td>p</td></tr><tr><td>D</td><td>589</td><td>8... |
8cc6ae50dc12b042e30c5928fda156a27a70ba0ce8aff0b72fb57ab3606c2a01.png | simple | <table><tr><td>Subgroup</td><td>No. of datasets</td><td>RR (95% CI)</td><td><i>I</i><sup>2</sup></td><td><i>P</i><sub>heterogeneity</sub></td></tr><tr><td>Total</td><td>7</td><td>1.06 (0.89, 1.26)</td><td>25%</td><td>0.24</td></tr><tr><td>Geographical area</td><td></td><td></td><td></td><td></td></tr><tr><td> North Ame... | <table><tr><td>Subgroup</td><td>No. of datasets</td><td>RR (95% CI)</td><td>I2</td><td>Pheterogeneity</td></tr><tr><td>Total</td><td>7</td><td>1.06 (0.89, 1.26)</td><td>25%</td><td>0.24</td></tr><tr><td>Geographical area</td><td></td><td></td><td></td><td></td></tr></table> | <table><tr><td>Subgroup</td><td>No. of datasets</td><td>RR (95% CI)</td><td>I2</td><td>Pheterogeneity</td></tr><tr><td>North America</td><td>4</td><td>1.11 (0.79, 1.56)</td><td>62%</td><td>0.05</td></tr><tr><td>Europe</td><td>3</td><td>1.05 (0.85, 1.32)</td><td>0%</td><td>0.98</td></tr><tr><td>Menopausal status</td><td... |
2f7aa2f9a8289303fb8d00a9269cf26b016de08273e52f99266c0d1ea853ba7a.png | complex | <table><tr><td></td><td>K</td><td>AIC</td><td>ΔAICc</td><td>wi</td></tr><tr><td colspan="5">All species</td></tr><tr><td> Distance to road</td><td>2</td><td>2401.35</td><td>0</td><td>0.78</td></tr><tr><td> Constant survival</td><td>1</td><td>2405.17</td><td>3.82</td><td>0.11</td></tr><tr><td> Distance to edge</td>... | <table><tr><td></td><td>K</td><td>AIC</td><td>ΔAICc</td></tr><tr><td colspan="4">All species</td></tr><tr><td>Distance to road</td><td>2</td><td>2401.35</td><td>0</td></tr><tr><td>Constant survival</td><td>1</td><td>2405.17</td><td>3.82</td></tr><tr><td>Distance to edge</td><td>2</td><td>2406.59</td><td>5.24</td></tr><... | <table><tr><td>wi</td></tr><tr><td>All species</td></tr><tr><td>0.78</td></tr><tr><td>0.11</td></tr><tr><td>0.06</td></tr><tr><td>0.05</td></tr><tr><td>0.00</td></tr><tr><td>0.00</td></tr><tr><td>BLGR</td></tr><tr><td>0.48</td></tr><tr><td>0.26</td></tr><tr><td>0.13</td></tr><tr><td>0.10</td></tr><tr><td>0.02</td></tr>... |
b4cd3a4bff1213707ba132ebf85804b07c7011591b0f2ef74e6d50af37f21a83.png | complex | <table><tr><td rowspan="2">Characteristics</td><td>CMV infection</td><td>No CMV infection</td><td rowspan="2">p</td></tr><tr><td><i>N</i> = 21</td><td><i>N</i> = 65</td></tr><tr><td>Age, mean ± SD, y</td><td>51.4 ± 13.8</td><td>46.8 ± 15.6</td><td>0.244</td></tr><tr><td>Gender, male (%)</td><td>57.1</td>... | <table><tr><td rowspan="2">Characteristics</td><td>CMV infection</td><td>No CMV infection</td><td rowspan="2">p</td></tr><tr><td>N = 21</td><td>N = 65</td></tr><tr><td>Age, mean ± SD, y</td><td>51.4 ± 13.8</td><td>46.8 ± 15.6</td><td>0.244</td></tr><tr><td>Gender, male (%)</td><td>57.1</td><td>69.2</td><td>0.308</td></... | <table><tr><td rowspan="2">Characteristics</td><td>CMV infection</td><td>No CMV infection</td><td rowspan="2">p</td></tr><tr><td>N = 21</td><td>N = 65</td></tr><tr><td>ay 0</td><td>3</td><td>7</td><td>000</td></tr><tr><td>Day 30</td><td>42.9/21.0</td><td>57.1/79.0</td><td>0.090</td></tr><tr><td>Day 90</td><td>53.8/20.0... |
8c0d539b86da4c1596462b60a57fd48e652a9c31f075abd7a2d5d22955d37515.png | complex | <table><tr><td>Characteristic</td><td>Total Group (<i>n</i> = 270)</td><td>IR (<i>n</i> = 183)</td><td>ID/IDA (<i>n</i> = 87)</td><td><i>p</i>-Value <sup>1</sup></td></tr><tr><td>Age (years)</td><td>25.9 ± 5.0</td><td>26.3 ± 4.9</td><td>25.3 ± 5.2</td><td>0.131</td></tr><tr><td>Highest Educational Attain... | <table><tr><td>Characteristic</td><td>Total Group (n = 270)</td><td>IR (n = 183)</td><td>ID/IDA (n = 87)</td><td>p-Value 1</td></tr><tr><td>Age (years)</td><td>25.9 ± 5.0</td><td>26.3 ± 4.9</td><td>25.3 ± 5.2</td><td>0.131</td></tr></table> | <table><tr><td>Characteristic</td><td>Total Group (n = 270)</td><td>IR (n = 183)</td><td>ID/IDA (n = 87)</td><td>p-Value 1</td></tr><tr><td>Highest Educational Attainment 2 (n, %)</td><td></td><td></td><td></td><td></td></tr><tr><td>Secondary</td><td>75 (27.8)</td><td>41 (22.4)</td><td>34 (39.1)</td><td rowspan="3">0.0... |
2eac6cb73cf919098b0ba55d7439015c6903e4febe9e664af6d823a182e7488b.png | simple | <table><tr><td></td><td>Gene name</td><td>Gene Accession number</td><td>Score (d)</td><td>Log<sub>2 </sub>expression ratio</td></tr><tr><td>Genes mainly expressed in skeletal muscle</td><td>Nebulette (Actin-binding Z-disk protein)</td><td>NM_006393</td><td>42.93</td><td>3.81</td></tr><tr><td></td><td>Troponin I, fast s... | <table><tr><td></td><td>Gene name</td><td>Gene Accession number</td><td>Score (d)</td><td>Log2 expression ratio</td></tr><tr><td>Genes mainly expressed in skeletal muscle</td><td>Nebulette (Actin-binding Z-disk protein)</td><td>NM_006393</td><td>42.93</td><td>3.81</td></tr><tr><td></td><td>Troponin I, fast skeletal mus... | <table><tr><td></td><td>Gene name</td><td>Gene Accession number</td><td>Score (d)</td><td>Log2 expression ratio</td></tr><tr><td></td><td>Myosin heavy chain, skeletal muscle, perinatal</td><td>NM_002472</td><td>28.14</td><td>2.80</td></tr><tr><td></td><td>Troponin T, fast skeletal muscle isoforms</td><td>NM_006757</td>... |
fc58b38499cd6e987e8b8f7083561daa3660c820e9140e8742402c661ce5b046.png | simple | <table><tr><td>Gene ID<sup>a</sup></td><td>Primers (5′-3′)</td><td>Accession No.</td><td>Amplicon length</td></tr><tr><td><i>Act- β</i></td><td>Forward: CGGCATCGAGGACAGGATReverse: CATCGTACTCCTGCTTGCTGAT</td><td>NM_173979.3</td><td>169</td></tr><tr><td><i>GAPDH</i></td><td>Forward: CCTGCCCGTTCGACAGATARe... | <table><tr><td>Gene IDa</td><td>Primers (5′-3′)</td><td>Accession No.</td><td>Amplicon length</td></tr><tr><td>Act- β</td><td>Forward: CGGCATCGAGGACAGGATReverse: CATCGTACTCCTGCTTGCTGAT</td><td>NM_173979.3</td><td>169</td></tr><tr><td>GAPDH</td><td>Forward: CCTGCCCGTTCGACAGATAReverse: GGCGACGATGTCCACTTTG</td><td>NM_0010... | <table><tr><td>Gene IDa</td><td>Primers (5′-3′)</td><td>Accession No.</td><td>Amplicon length</td></tr><tr><td>HPRT1</td><td>Forward:GGATTACATCAAAGCACTGAACAReverse: CATTGTCTTCCCAGTGTCAATT</td><td>NM_001034035</td><td>194</td></tr></table> |
f47fe9fbf6eb0dddbe4dc76e2d0c8760c8f2824b14f92e28f1ea3322eaa9b1bb.png | complex | <table><tr><td rowspan="2">Characteristic/subcategory</td><td colspan="3">Discomfort of acupuncture: No. (%)</td><td colspan="2">No discomfort<sup>a</sup></td><td colspan="2">Slight discomfort<sup>a</sup></td></tr><tr><td>No</td><td>Slight</td><td>Moderate to severe</td><td>OR (95% CI)</td><td><i>P</i> value</td><td>OR... | <table><tr><td rowspan="2">Characteristic/subcategory</td><td colspan="3">Discomfort of acupuncture: No. (%)</td><td colspan="2">No discomforta</td><td colspan="2">Slight discomforta</td></tr><tr><td>No</td><td>Slight</td><td>Moderate to severe</td><td>OR (95% CI)</td><td>P value</td><td>OR (95% CI)</td><td>P value</td... | <table><tr><td>≥70</td><td>20 (18.1)</td><td>51 (46.4)</td><td>39 (35.5)</td><td>1.00</td><td></td><td>1.00</td><td></td></tr><tr><td>≤19</td><td>7 (12.3)</td><td>35 (61.4)</td><td>15 (26.3)</td><td>1.12 (0.37–3.41)</td><td>0.841</td><td>2.02 (0.94–4.32)</td><td>0.070</td></tr><tr><td>20–29</td><td>8 (5.7)</td><td>76 (... |
47a22320ac4d1e6a0e386dc0b45162385b9ef4607beee2de69be7d30466df77e.png | complex | <table><tr><td rowspan="2">Characteristics</td><td rowspan="2">Category</td><td colspan="2">NSSIs</td><td rowspan="2">p-value</td></tr><tr><td>Present</td><td>Absent</td></tr><tr><td>Faculty</td><td>MBBS</td><td>18 (64.3)</td><td>10 (35.7)</td><td></td></tr><tr><td></td><td>BDS</td><td>9 (56.3)</td><td>7 (43.8)</td><td... | <table><tr><td rowspan="2">Characteristics</td><td rowspan="2">Category</td><td colspan="2">NSSIs</td><td rowspan="2">p-value</td></tr><tr><td>Present</td><td>Absent</td></tr><tr><td>Faculty</td><td>MBBS</td><td>18 (64.3)</td><td>10 (35.7)</td><td></td></tr><tr><td></td><td>BDS</td><td>9 (56.3)</td><td>7 (43.8)</td><td... | <table><tr><td rowspan="2">Characteristics</td><td rowspan="2">Category</td><td colspan="2">NSSIs</td><td rowspan="2">p-value</td></tr><tr><td>Present</td><td>Absent</td></tr><tr><td>Nationality</td><td>Nepalese</td><td>87 (42.4)</td><td>118 (57.6)</td><td>0.653</td></tr><tr><td></td><td>Indian</td><td>3 (60.0)</td><td... |
6e00717f57a2ce0cb9b5acc8e91f757f0de250296db88ce6b72596540616be71.png | complex | <table><tr><td>Item</td><td>Descriptions</td></tr><tr><td>Number of stations</td><td>12</td></tr><tr><td>Date span </td><td>1–30 May 2015; 1–30 July 2016</td></tr><tr><td>Signal selection</td><td>GPS: L1/L2/L5; GLONASS: L1/L2; BeiDou: B1/B2/B3; Galileo: E1/E5a/E5b</td></tr><tr><td>Sampling interval</td><td>... | <table><tr><td>Item</td></tr><tr><td>Number of stations</td></tr><tr><td>Date span</td></tr><tr><td>Signal selection</td></tr><tr><td>Sampling interval</td></tr><tr><td>Elevation cut off</td></tr><tr><td>Time system</td></tr><tr><td>Tropospheric delay</td></tr><tr><td rowspan="5">First order ionospheric delay</td></tr>... | <table><tr><td>Descriptions</td></tr><tr><td>12</td></tr><tr><td>1–30 May 2015; 1–30 July 2016</td></tr><tr><td>GPS: L1/L2/L5; GLONASS: L1/L2; BeiDou: B1/B2/B3; Galileo: E1/E5a/E5b</td></tr><tr><td>30 s</td></tr><tr><td>10°</td></tr><tr><td>GPS time</td></tr><tr><td>Dry component: corrected with GPT model [26], wet com... |
5208217a0cf4440035ef28e260176bdda86ffd7d1ee3fe71093e9aafaa0bddd5.png | complex | <table><tr><td rowspan="2">Ethnic group</td><td colspan="3"><i>α</i>-globin genotypes</td><td>Total</td></tr><tr><td>- -<i>α</i><sup>3.7</sup>/<i>αα</i></td><td>- -<i>α</i><sup>4.2</sup>/<i>αα</i></td><td>- -<sup>SEA</sup>/<i>αα</i></td></tr><tr><td>Malay (<i>n</i> = 315)</t... | <table><tr><td rowspan="2">Ethnic group</td><td colspan="3">α-globin genotypes</td><td>Total</td></tr><tr><td>- -α3.7/αα</td><td>- -α4.2/αα</td><td>- -SEA/αα</td><td></td></tr></table> | <table><tr><td>Malay (n = 315)</td><td>32</td><td>0</td><td>1</td><td>33</td></tr><tr><td>Chinese (n = 73)</td><td>2</td><td>1</td><td>1</td><td>4</td></tr><tr><td>Indian (n = 12)</td><td>0</td><td>0</td><td>0</td><td>0</td></tr><tr><td>Total (n = 400)</td><td>34</td><td>1</td><td>2</td><td>37</td></tr></table> |
ece74e5f526bffcf8d87170862cfdc1699804123fa29822068e81f06b49bdf91.png | complex | <table><tr><td>Strain</td><td><i>D</i></td><td><i>Y</i><sub><i>xs</i></sub></td><td>r<sub>s</sub></td><td>r<sub>CO2</sub></td><td>r<sub>O2</sub></td><td>r<sub>etoh</sub></td><td>r<sub>acet</sub></td><td>RQ</td><td>C<sub>s</sub></td><td>C<sub>balance</sub></td><td>Tot<sub>sant</sub></td></tr><tr><td> </td><td>(h<sup>-1<... | <table><tr><td>Strain</td><td>D</td><td>Yxs</td><td>rs</td><td>rCO2</td><td>rO2</td><td>retoh</td><td>racet</td><td>RQ</td><td>Cs</td><td>Cbalance</td><td>Totsant</td></tr><tr><td></td><td>(h-1)</td><td>(g g-1)</td><td colspan="5">(mmol g biomass-1h-1)</td><td>(rCO2/rO2)</td><td>(mM)</td><td>(%)</td><td>(mg 24 h-1l-1)<... | <table><tr><td rowspan="2">SCIGS28</td><td>0.051 ±0.002</td><td>0.50 ±0.01</td><td>0.57 ±0.01</td><td>1.12 ±0.08</td><td>1.12 ±0.06</td><td>0</td><td>0</td><td>1.00 ±0.02</td><td>0.18 ±0.02</td><td>100.3 ±2.1</td><td>11.8 ±0.3</td></tr><tr><td>0.10 ±0.01</td><td>0.50 ±0.01</td><td>1.11 ±0.03</td><td>2.67 ±0.15</td><td>... |
88346badf41ed8c653c7b679715cc8ac34a4fc79c023ac080be59a2358f6723b.png | complex | <table><tr><td>PPI Dataset</td><td>Methods</td><td>Precision</td><td>Recall</td><td><i>F</i>-score</td><td>Sn</td><td>PPV</td><td>Accuracy</td></tr><tr><td rowspan="10">DIP</td><td>CDUN</td><td>0.6</td><td>0.551</td><td>0.575</td><td>0.431</td><td>0.641</td><td>0.526</td></tr><tr><td>CSO</td><td>0.497</td><td>0.623</td... | <table><tr><td>PPI Dataset</td><td>Methods</td><td>Precision</td></tr><tr><td rowspan="10">DIP</td><td>CDUN</td><td>0.6</td></tr><tr><td>CSO</td><td>0.497</td></tr><tr><td>Cluster ONE</td><td>0.337</td></tr><tr><td>COAN</td><td>0.41</td></tr><tr><td>COACH</td><td>0.307</td></tr><tr><td>CMC</td><td>0.485</td></tr><tr><t... | <table><tr><td>Recall</td><td>F-score</td><td>Sn</td><td>PPV</td><td>Accuracy</td></tr><tr><td>0.551</td><td>0.575</td><td>0.431</td><td>0.641</td><td>0.526</td></tr><tr><td>0.623</td><td>0.553</td><td>0.538</td><td>0.631</td><td>0.582</td></tr><tr><td>0.441</td><td>0.382</td><td>0.378</td><td>0.696</td><td>0.513</td><... |
287ea07aaade575b9758e32c25ce34f7c3c4200a8d1e81e70cfc6858630b5c3d.png | simple | <table><tr><td></td><td><i>M</i></td><td>SD</td><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td><td>6</td><td>7</td><td>8</td><td>9</td></tr><tr><td>Threat appraisal</td><td>54.34</td><td>14.84</td><td></td><td>0.00</td><td>0.27*</td><td>0.14</td><td>0.05</td><td>−0.32*</td><td>−0.27*</td><td>−0.08<... | <table><tr><td></td><td>M</td><td>SD</td><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td><td>6</td><td>7</td><td>8</td><td>9</td></tr><tr><td>Threat appraisal</td><td>54.34</td><td>14.84</td><td></td><td>0.00</td><td>0.27*</td><td>0.14</td><td>0.05</td><td>−0.32*</td><td>−0.27*</td><td>−0.08</td><td>−0.12</td></tr><t... | <table><tr><td>Rumination</td><td>28.53</td><td>7.43</td><td></td><td></td><td></td><td></td><td></td><td>0.46***</td><td>0.30*</td><td>0.69***</td><td>0.49***</td></tr><tr><td>Search for affiliation</td><td>32.58</td><td>9.23</td><td></td><td></td><td></td><td></td><td></td><td></td><td>0.57***</td><td>0.40**</td><td>... |
0d608731d643f4c0e17b447a7372c1e3ce858447d6131c08eacf862f6191d57b.png | simple | <table><tr><td>Species Name</td><td>LC50/EC50 (95% Confidence Interval Limit)</td><td>Study</td></tr><tr><td><i>Oreochromis niloticus</i></td><td>3760 mg∙L<sup>−1</sup> (2990–4010)</td><td>Omoregie et al. (2009) [39]</td></tr><tr><td><i>Chironomus yoshimatsui</i></td><td>1520 mg∙L<sup>−1</... | <table><tr><td>Species Name</td><td>LC50/EC50 (95% Confidence Interval Limit)</td><td>Study</td></tr><tr><td>Oreochromis niloticus</td><td>3760 mg∙L−1 (2990–4010)</td><td>Omoregie et al. (2009) [39]</td></tr><tr><td>Chironomus yoshimatsui</td><td>1520 mg∙L−1</td><td>Kegley et al. (2014) [40]</td></tr><tr><td>Viviparus ... | <table><tr><td>Radix luteola</td><td>3000 mg∙L−1</td><td>USEPA, (2015) [41]</td></tr></table> |
3cd5aad1750eccc665bb8196a0b256e5853e3a199533320e52950c281c91ddc1.png | complex | <table><tr><td rowspan="3"></td><td colspan="5">0.033 mg/kg/day</td><td colspan="5">0.067 mg/kg/day</td></tr><tr><td rowspan="2">Total</td><td rowspan="2">Glucose intolerant type</td><td colspan="3">Time point evaluated as the glucose intolerant type</td><td rowspan="2">Total</td><td rowspan="2">Glucose intolerant type... | <table><tr><td rowspan="3"></td><td colspan="5">0.033 mg/kg/day</td><td colspan="5">0.067 mg/kg/day</td></tr><tr><td rowspan="2">Total</td><td rowspan="2">Glucose intolerant type</td><td colspan="3">Time point evaluated as the glucose intolerant type</td><td rowspan="2">Total</td><td rowspan="2">Glucose intolerant type... | <table><tr><td></td><td></td><td>6.9 %)</td><td>%)</td><td>%)</td><td> (6.9 %)</td><td>0 %)</td><td> %)</td><td>0 (0.0 %)</td><td></td><td>.3 %)</td></tr><tr><td>156 weeks</td><td>25 (100 %)</td><td>1 (4.0 %)</td><td>0 (0.0 %)</td><td>0 (0.0 %)</td><td>1 (4.0 %)</td><td>29 (100 %)</td><td>2 (6.9 %)</td><td>0 (0.0 %)</t... |
699624555de8a0c9d0f986d43daeb22cb474764421dd6d845e7ead5906770bdb.png | simple | <table><tr><td></td><td>2010 audit<i>n</i> = 82</td><td>2011 re-audit<i>n</i> = 140</td></tr><tr><td>Patients who had at least one neuroimaging procedure (through MAS or previous), <i>n</i> (%)</td><td>56 (68)</td><td>106 (76)</td></tr><tr><td>Neuroimaging requested through MAS, <i>n</i> (%)</td><td>48 (59)</td><td>88 ... | <table><tr><td></td><td>2010 auditn = 82</td><td>2011 re-auditn = 140</td></tr><tr><td>Patients who had at least one neuroimaging procedure (through MAS or previous), n (%)</td><td>56 (68)</td><td>106 (76)</td></tr><tr><td>Neuroimaging requested through MAS, n (%)</td><td>48 (59)</td><td>88 (63)</td></tr><tr><td>Previo... | <table><tr><td></td><td>2010 auditn = 82</td><td>2011 re-auditn = 140</td></tr><tr><td>CT scan</td><td>49/56 (88)</td><td>92/106 (87)</td></tr><tr><td>MRI scan</td><td>5/56 (9)</td><td>14/106 (13)</td></tr><tr><td>Other (FDG-PET/CT, HMPAO-SPECT)</td><td>2/56 (4)</td><td>0/106 (0)</td></tr><tr><td>Coronal imaging on CT ... |
3e32bf3bc6ace359013f5f347f92efa37b2cdbab0168123d5778fb5b0dcfa0e3.png | simple | <table><tr><td> VA outcome</td><td>Fox (<i>n</i> = 19)</td><td>Clark (<i>n</i> = 36)</td><td>Al-Mezaine (<i>n</i> = 17)</td><td>Shirodkar (<i>n</i> = 26)</td><td>Overall (<i>n</i> = 98)</td></tr><tr><td>≥20/40</td><td>9 (47.3%)</td><td>18 (50%)</td><td>5 (29.4%)</td><td>13 (50%)</td><td>45 (45.9%)</td></tr><tr><t... | <table><tr><td>VA outcome</td><td>Fox (n = 19)</td><td>Clark (n = 36)</td><td>Al-Mezaine (n = 17)</td><td>Shirodkar (n = 26)</td><td>Overall (n = 98)</td></tr><tr><td>≥2</td><td>9 (47.</td><td>18</td><td>5 (29.</td><td>13</td><td>45 (4</td></tr></table> | <table><tr><td>0/40</td><td>3%)</td><td> (50%)</td><td>4%)</td><td> (50%)</td><td>5.9%)</td></tr><tr><td>20/50 ≥ 20/400</td><td>6 (31.5%)</td><td>10 (28%)</td><td>4 (23.5%)</td><td>6 (23%)</td><td>26 (26.5%)</td></tr><tr><td><20/400 ≥ 5/200</td><td>1 (5.2%)</td><td>2 (5%)</td><td>2 (11.7%)</td><td>2 (7.7%)</td><td>7 (7... |
baa80ddbc7e465c87aeb531eb30f4022acc001723396e2f4c6ea0d91bc78a585.png | simple | <table><tr><td>Parameter</td><td>Definition</td></tr><tr><td><i>N</i></td><td>Number of individuals in the population</td></tr><tr><td><i>Z</i></td><td>Probability to reproduce by self-fertilization</td></tr><tr><td><i>w</i></td><td>Fitness of an individual</td></tr><tr><td><i>n</i></td><td>Number of TE copies in the g... | <table><tr><td>Parameter</td><td>Definition</td></tr><tr><td>N</td><td>Number of individuals in the population</td></tr><tr><td>Z</td><td>Probability to reproduce by self-fertilization</td></tr><tr><td>w</td><td>Fitness of an individual</td></tr><tr><td>n</td><td>Number of TE copies in the genome</td></tr></table> | <table><tr><td>Parameter</td><td>Definition</td></tr><tr><td>si</td><td>Effect of insertion i on fitness</td></tr><tr><td>μs</td><td>Average effect of TE insertions on fitness</td></tr><tr><td>σs</td><td>Standard deviation of the effect on fitness</td></tr><tr><td>Ps > 0</td><td>Proportion of TE insertions that improve... |
6bd895bf47a58dd5df7c3566de7a8e68a34fcf868f004eb4a944fe6021d28473.png | complex | <table><tr><td rowspan="2">Gene list</td><td rowspan="2"><i>N</i> genes</td><td colspan="2">Proportion of genome</td><td colspan="2">SNP heritability (<i>P</i> value)</td></tr><tr><td>SNPs</td><td>Mb</td><td>All samples</td><td>Infliximab+Adalimumab</td></tr><tr><td>Whole genome</td><td>—</td><td>1</td><td>1</td>... | <table><tr><td rowspan="2">Gene list</td><td rowspan="2">N genes</td><td colspan="2">Proportion of genome</td></tr><tr><td>SNPs</td><td>Mb</td></tr><tr><td>Whole genome</td><td>—</td><td>1</td><td>1</td></tr><tr><td>Drug metabolism*</td><td>215</td><td>0.07</td><td>0.10</td></tr><tr><td>Immune-related†</td><td>6,001</t... | <table><tr><td colspan="2">SNP heritability (P value)</td></tr><tr><td>All samples</td><td>Infliximab+Adalimumab</td></tr><tr><td>0.18 (0.02)</td><td>0.36 (0.005)</td></tr><tr><td>0.05 (0.3)</td><td>0.04 (0.09)</td></tr><tr><td>0.07 (0.2)</td><td>0.21 (0.01)</td></tr><tr><td>0.05 (0.04)</td><td>0.02 (0.3)</td></tr><tr>... |
44213c275d4d96ebbfe657bb946107affc0d04a10b30eecfa2a4fee8ef747bb7.png | simple | <table><tr><td>Sample</td><td>[M]/[I]</td><td>m<sub>M</sub>, g</td><td>m<sub>C</sub>, mg</td></tr><tr><td>MWS-1 MWS-2 MWS-3</td><td>1/1,000</td><td>5</td><td>14.05</td></tr><tr><td>MWS-4 MWS-5 MWS-6</td><td>1/5,000</td><td>5</td><td>2.81</td></tr><tr><td>MWS-7 MWS-8 MWS-9</td><td>1/10,000</td><td>5</td><td>1.41</td></t... | <table><tr><td>Sample</td></tr><tr><td>MWS-1 MWS-2 MWS-3</td></tr><tr><td>MWS-4 MWS-5 MWS-6</td></tr><tr><td>MWS-7 MWS-8 MWS-9</td></tr></table> | <table><tr><td>[M]/[I]</td><td>mM, g</td><td>mC, mg</td></tr><tr><td>1/1,000</td><td>5</td><td>14.05</td></tr><tr><td>1/5,000</td><td>5</td><td>2.81</td></tr><tr><td>1/10,000</td><td>5</td><td>1.41</td></tr></table> |
c277c51f747cd593c8f41af26f2ed557b01005d51a81e8a7ada3981b25019a19.png | simple | <table><tr><td>Human protein</td><td>Targeting DNA virus families</td><td>Targeting RNA virus families</td></tr><tr><td>HNRPK – heterogeneous nuclear ribonucleoprotein K</td><td>Asfarviridae, Herpesviridae, Papillomaviridae, Poxviridae</td><td>Arteriviridae, Filoviridae, Flaviviridae, Orthomyxoviridae, Paramyxovi... | <table><tr><td>Human protein</td></tr><tr><td>HNRPK – heterogeneous nuclear ribonucleoprotein K</td></tr><tr><td>YBOX1 – nuclease‐sensitive element‐binding protein 1</td></tr><tr><td>EF1A1 – elongation factor 1‐alpha 1</td></tr><tr><td>IMA1 – Importin subunit alpha‐1</td></tr><tr><td>ADT2 – ADP/ATP translocase 2</td></... | <table><tr><td>Targeting DNA virus families</td><td>Targeting RNA virus families</td></tr><tr><td>Asfarviridae, Herpesviridae, Papillomaviridae, Poxviridae</td><td>Arteriviridae, Filoviridae, Flaviviridae, Orthomyxoviridae, Paramyxoviridae, Togaviridae</td></tr><tr><td>Herpesviridae, Papillomaviridae, Polyomaviridae, P... |
c13f629e5b430c86f1357ec7ce14ba712f151a43347baed668f33391701d12db.png | simple | <table><tr><td>Stage of Lactation (Month)</td><td>2</td><td>5</td><td>9</td><td>12</td></tr><tr><td>Maternal age (years)</td><td>32.9 ± 4.21 (28–40)</td><td>33.4 ± 4.27 (24–40)</td><td>34.0 ± 4.57 (25–43)</td><td>34.1 ± 4.35 (26–44)</td></tr><tr><td>Maternal BMI</td><td>27.1 ... | <table><tr><td>Stage of Lactation (Month)</td></tr><tr><td>Maternal age (years)</td></tr><tr><td>Maternal BMI</td></tr><tr><td>Parity</td></tr><tr><td>Infant sex (Male/Female)</td></tr><tr><td>Infant birth weight (kg)</td></tr><tr><td>Infant body length (cm)</td></tr></table> | <table><tr><td>2</td><td>5</td><td>9</td><td>12</td></tr><tr><td>32.9 ± 4.21 (28–40)</td><td>33.4 ± 4.27 (24–40)</td><td>34.0 ± 4.57 (25–43)</td><td>34.1 ± 4.35 (26–44)</td></tr><tr><td>27.1 ± 7.15 (20.1–38.5)</td><td>23.5 ± 4.46 (18.0–35.2)</td><td>24.0 ± 5.15 (18.7–37.2)</td><td>24.8 ± 5.6 (18.2–34.6)</td></tr><tr><t... |
ea4e261ee1223fe99ca8478bcc4abe5548b993b1b04ed09891db77ad2bd2cd94.png | simple | <table><tr><td>Group</td><td><i>E</i><sub>1</sub>′ (MPa)</td><td><i>E</i><sub>2</sub>′ (MPa)</td><td><i>t<sub>s</sub></i> (min)</td><td><i>G</i><sub>∞</sub></td><td><i>R</i><sup>2</sup></td></tr><tr><td>L65</td><td>10.1408 ± 5.8173</td><td>16.4475 ± 5.8594</td><td>0.6501 ± 0.1888</td><t... | <table><tr><td>Group</td><td>E1′ (MPa)</td><td>E2′ (MPa)</td><td>ts (min)</td><td>G∞</td><td>R2</td></tr></table> | <table><tr><td>L65</td><td>10.1408 ± 5.8173</td><td>16.4475 ± 5.8594</td><td>0.6501 ± 0.1888</td><td>0.4174 ± 0.0479</td><td>0.7877 ± 0.0257</td></tr><tr><td>L60</td><td>5.9513 ± 3.0988</td><td>9.1808 ± 2.9271</td><td>0.7275 ± 0.0806</td><td>0.3785 ± 0.0676</td><td>0.8254 ± 0.0134</td></tr><tr><td>R</td><td>1.2904 ± 0.... |
d190e1141ad8cca78d53b58df7f1c57cfce82fcae54db22fbae1ff71b09548f3.png | complex | <table><tr><td rowspan="2" colspan="2">Characteristics</td><td rowspan="2">Yes <i>n</i> (%)</td><td colspan="3">Non-compliance to HPV vaccination</td></tr><tr><td>Prevalence</td><td><i>p</i> value</td><td>Odds Ratio (CI 95 %)</td></tr><tr><td rowspan="2">Parent’s religion</td><td>Protestant</td><td>262 (44,1 %)</... | <table><tr><td rowspan="2" colspan="2">Characteristics</td><td rowspan="2">Yes n (%)</td><td colspan="3">Non-compliance to HPV vaccination</td></tr><tr><td>Prevalence</td><td>p value</td><td>Odds Ratio (CI 95 %)</td></tr><tr><td rowspan="2">Parent’s religion</td><td>Protestant</td><td>262 (44,1 %)</td><td>17,9 %</td><t... | <table><tr><td>Knowing that men are affected by HPV</td><td>Right</td><td>348 (43,7 %)</td><td>16,3 %</td><td></td><td>1</td></tr><tr><td rowspan="2">Knowing that HPV causes genital warts</td><td>Wrong</td><td>484 (60,7 %)</td><td>18,8 %</td><td>ns</td><td>1,41 (0,92–2,17)</td></tr><tr><td>Right</td><td>313 (39,3 %)</t... |
9e895e56080131bdb7cd0c964d77a55d7a9bf7cb7f4c4632d949d186d9e07b14.png | complex | <table><tr><td>Population</td><td>IDF guideline recommendation</td><td>Assessment in study</td></tr><tr><td>All acne patients</td><td>Assign treatment according to acne severity</td><td>Not assessed in study: could not be evaluated by computerized query (Disease severity not stated within diagnosis field)</td></tr><tr>... | <table><tr><td>Population</td><td>IDF guideline recommendation</td><td>Assessment in study</td></tr><tr><td>All acne patients</td><td>Assign treatment according to acne severity</td><td>Not assessed in study: could not be evaluated by computerized query (Disease severity not stated within diagnosis field)</td></tr><tr>... | <table><tr><td>Female patients treated with oral retinoids (teratogenic)</td><td>- Have the patient sign a statement and file in their medical record (see background).</td><td>Documented concomitant prescribing or dispensing of oral contraceptives to female patients receiving OI’s.</td></tr></table> |
4c2e55aa7ded48d4d5452fb0c4e26b6a092d76f9f66d87e85a92f5cade747c4b.png | simple | <table><tr><td>Characteristic</td><td>No. of patients</td><td>%</td></tr><tr><td>Patients evaluable</td><td>70</td><td>100</td></tr><tr><td>Age, years</td><td> </td><td> </td></tr><tr><td> Median (range)</td><td>65 (32–75)</td><td> </td></tr><tr><td>Sex</td><td> </td><td> </td></tr><tr><td> Male</td><td>41</td><t... | <table><tr><td>Characteristic</td><td>No. of patients</td></tr><tr><td>Patients evaluable</td><td>70</td></tr><tr><td>Age, years</td><td></td></tr><tr><td>Median (range)</td><td>65 (32–75)</td></tr><tr><td>Sex</td><td></td></tr><tr><td>Male</td><td>41</td></tr><tr><td>Female</td><td>29</td></tr><tr><td>Response to prio... | <table><tr><td>%</td></tr><tr><td>100</td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr><tr><td>58.5</td></tr><tr><td>41.5</td></tr><tr><td></td></tr><tr><td>63</td></tr><tr><td>37</td></tr><tr><td></td></tr><tr><td>36</td></tr><tr><td>64</td></tr><tr><td></td></tr><tr><td>47.2</td></tr><tr><td>41.4</td></... |
99f9a631ead7412b09e0504a0bd9b1fc40d42fd74e693e3b86df037a7d218204.png | simple | <table><tr><td> </td><td>1995</td><td>1996</td><td>1997</td><td>1998</td><td>1999</td><td>2000</td><td>2001</td><td>2002</td><td>2003</td><td>2004</td><td>2005</td><td>2006</td><td>2007</td><td>2008</td><td>2009</td><td>2010</td><td>2011</td><td>Sum</td><td>%</td></tr><tr><td>jan</td><td> </td><td> </td><td> </td><td> ... | <table><tr><td></td><td>1995</td><td>1996</td><td>1997</td><td>1998</td><td>1999</td><td>2000</td><td>2001</td><td>2002</td><td>2003</td><td>2004</td><td>2005</td><td>2006</td><td>2007</td><td>2008</td><td>2009</td><td>2010</td><td>2011</td><td>Sum</td><td>%</td></tr><tr><td>jan</td><td></td><td></td><td></td><td></td>... | <table><tr><td></td><td>1995</td><td>1996</td><td>1997</td><td>1998</td><td>1999</td><td>2000</td><td>2001</td><td>2002</td><td>2003</td><td>2004</td><td>2005</td><td>2006</td><td>2007</td><td>2008</td><td>2009</td><td>2010</td><td>2011</td><td>Sum</td><td>%</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td... |
ce8cb00dc3be216bae94abdec50453a878b5c15414a982fb63f2832b1531349b.png | complex | <table><tr><td></td><td>Lipid emulsion (n = 16)</td><td>Control (n = 11)</td></tr><tr><td>Initiation of enteral nutrition (h)</td><td>10.63 ± 5.49</td><td>9.27 ± 6.69</td></tr><tr><td>Age at feeds >100 mL/kg per day (days)</td><td>11.69 ± 4.75</td><td>7.55 ± 3.77*</td></tr><tr><td>Period of paren... | <table><tr><td></td><td>Lipid emulsion (n = 16)</td></tr><tr><td>Initiation of enteral nutrition (h)</td><td>10.63 ± 5.49</td></tr><tr><td>Age at feeds >100 mL/kg per day (days)</td><td>11.69 ± 4.75</td></tr><tr><td>Period of parenteral nutrition (days)</td><td>12.75 ± 5.84</td></tr><tr><td>Human milk/enteral nutrition... | <table><tr><td>Control (n = 11)</td></tr><tr><td>9.27 ± 6.69</td></tr><tr><td>7.55 ± 3.77*</td></tr><tr><td>8.91 ± 3.70*</td></tr><tr><td>73.84 ± 39.72</td></tr><tr><td>Lipid emulsion</td></tr><tr><td>–</td></tr><tr><td>–</td></tr><tr><td>–</td></tr><tr><td>–</td></tr></table> |
b8c8a05ec61d775e5b2f72d5462549fa06c2a38b48d359d2b71a602a1f243fb4.png | complex | <table><tr><td rowspan="2">Indicator</td><td colspan="2">Participants<sup>a</sup></td><td rowspan="2"><i>P</i></td></tr><tr><td>With probable depression at baseline(<i>n</i> = 309)</td><td>Without probable depression at baseline(<i>n</i> = 266)</td></tr><tr><td>Treatment outcome, no. (%)</td><td></td><td></td><td></td>... | <table><tr><td rowspan="2">Indicator</td><td colspan="2">Participantsa</td><td rowspan="2">P</td></tr><tr><td>With probable depression at baseline(n = 309)</td><td>Without probable depression at baseline(n = 266)</td></tr><tr><td>Treatment outcome, no. (%)</td><td></td><td></td><td></td></tr><tr><td>Treatment success</... | <table><tr><td rowspan="2">Indicator</td><td colspan="2">Participantsa</td><td rowspan="2">P</td></tr><tr><td>With probable depression at baseline(n = 309)</td><td>Without probable depression at baseline(n = 266)</td></tr><tr><td>Disability score, median(IQR)c,d</td><td></td><td></td><td></td></tr><tr><td>At baseline b... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.